Cluster composition

Functions

Category	Name	IntersectionWithQuery	PValue	GenesInTerm	GenesInQuery	GenesInTermInQuery	ID
GeneOntologyMolecularFunction	kinase activity	TLK2 ERBB2 CAD RIPK1 WEE1 MARK3 GRK7 DAPK2 PAK5 IRAK1 DAPK1 DAPK3 RBKS AK7 ADK EGFR PIK3CB CSNK1G2 EPHA2 PRKDC MAP2K2	1.71e-06	764	167	21	GO:0016301
GeneOntologyMolecularFunction	phosphotransferase activity, alcohol group as acceptor	TLK2 ERBB2 CAD RIPK1 WEE1 MARK3 GRK7 DAPK2 PAK5 IRAK1 DAPK1 DAPK3 RBKS ADK EGFR PIK3CB CSNK1G2 EPHA2 PRKDC MAP2K2	2.08e-06	709	167	20	GO:0016773
GeneOntologyMolecularFunction	protein kinase activity	TLK2 ERBB2 CAD RIPK1 WEE1 MARK3 GRK7 DAPK2 PAK5 IRAK1 DAPK1 DAPK3 EGFR PIK3CB CSNK1G2 EPHA2 PRKDC MAP2K2	2.98e-06	600	167	18	GO:0004672
GeneOntologyMolecularFunction	transferase activity, transferring phosphorus-containing groups	TLK2 ERBB2 CAD RIPK1 WEE1 MARK3 GRK7 DAPK2 PAK5 IRAK1 DAPK1 OAS3 DAPK3 RBKS PTDSS2 AK7 ADK EGFR PIK3CB CSNK1G2 EPHA2 PRKDC MAP2K2	3.62e-06	938	167	23	GO:0016772
GeneOntologyMolecularFunction	intramembrane lipid transporter activity	VMP1 ABCA2 ABCA3 ABCA4 ABCA7 ANO8	4.12e-06	51	167	6	GO:0140303
GeneOntologyMolecularFunction	protein serine/threonine kinase activity	TLK2 RIPK1 MARK3 GRK7 DAPK2 PAK5 IRAK1 DAPK1 DAPK3 EGFR PIK3CB CSNK1G2 PRKDC MAP2K2	2.41e-05	446	167	14	GO:0004674
GeneOntologyMolecularFunction	protein serine kinase activity	TLK2 RIPK1 MARK3 DAPK2 PAK5 IRAK1 DAPK1 DAPK3 PIK3CB CSNK1G2 PRKDC MAP2K2	5.71e-05	363	167	12	GO:0106310
GeneOntologyMolecularFunction	succinate-CoA ligase (GDP-forming) activity	SUCLG2 SUCLG1	6.95e-05	2	167	2	GO:0004776
GeneOntologyMolecularFunction	glycerol-3-phosphate dehydrogenase (NAD+) activity	GPD1 GPD1L	6.95e-05	2	167	2	GO:0141152
GeneOntologyMolecularFunction	glycerol-3-phosphate dehydrogenase [NAD(P)+] activity	GPD1 GPD1L	6.95e-05	2	167	2	GO:0047952
GeneOntologyMolecularFunction	ATPase-coupled intramembrane lipid transporter activity	ABCA2 ABCA3 ABCA4 ABCA7	8.26e-05	28	167	4	GO:0140326
GeneOntologyMolecularFunction	succinate-CoA ligase (ADP-forming) activity	SUCLG2 SUCLG1	2.07e-04	3	167	2	GO:0004775
GeneOntologyMolecularFunction	succinate-CoA ligase activity	SUCLG2 SUCLG1	2.07e-04	3	167	2	GO:0004774
GeneOntologyMolecularFunction	iron-responsive element binding	ACO1 IREB2	2.07e-04	3	167	2	GO:0030350
GeneOntologyMolecularFunction	aconitate hydratase activity	ACO1 IREB2	2.07e-04	3	167	2	GO:0003994
GeneOntologyMolecularFunction	NAD binding	GPD1 AOX1 GPD1L EHHADH UGDH	3.66e-04	73	167	5	GO:0051287
GeneOntologyMolecularFunction	phospholipid transporter activity	VMP1 ABCA3 ABCA4 ABCA7 ANO8	3.90e-04	74	167	5	GO:0005548
GeneOntologyMolecularFunction	delta(3)-delta(2)-enoyl-CoA isomerase activity	EHHADH ECI2	4.13e-04	4	167	2	GO:0004165
GeneOntologyMolecularFunction	minus-end-directed microtubule motor activity	DNAH10 DNAH2 DNAH9	4.27e-04	18	167	3	GO:0008569
GeneOntologyMolecularFunction	HLA-A specific inhibitory MHC class I receptor activity	LILRA1 LILRB2	6.84e-04	5	167	2	GO:0030107
GeneOntologyMolecularFunction	ABC-type transporter activity	ABCA2 ABCA3 ABCA4 ABCA7	7.46e-04	49	167	4	GO:0140359
GeneOntologyMolecularFunction	HLA-B specific inhibitory MHC class I receptor activity	LILRA1 LILRB2	1.02e-03	6	167	2	GO:0030109
GeneOntologyMolecularFunction	flavin adenine dinucleotide binding	AOX1 POR TXNRD2 TXNRD1 SDHA	1.16e-03	94	167	5	GO:0050660
GeneOntologyMolecularFunction	ATP hydrolysis activity	ABCA2 ABCA3 ABCA4 TDRD9 DNAH10 DNAH2 MORC4 ABCA7 NAV3 KIF14 DNAH9	1.25e-03	441	167	11	GO:0016887
GeneOntologyMolecularFunction	thioredoxin-disulfide reductase (NADPH) activity	TXNRD2 TXNRD1	1.42e-03	7	167	2	GO:0004791
GeneOntologyMolecularFunction	MHC class Ib protein complex binding	LILRA1 LILRB2	1.42e-03	7	167	2	GO:0023025
GeneOntologyMolecularFunction	dynein light intermediate chain binding	DNAH10 DNAH2 DNAH9	1.61e-03	28	167	3	GO:0051959
GeneOntologyMolecularFunction	serine-type peptidase activity	PRSS3 RELN TMPRSS12 F9 PROZ GZMA TMPRSS3	1.82e-03	207	167	7	GO:0008236
GeneOntologyMolecularFunction	serine hydrolase activity	PRSS3 RELN TMPRSS12 F9 PROZ GZMA TMPRSS3	2.08e-03	212	167	7	GO:0017171
GeneOntologyMolecularFunction	ribonucleoside triphosphate phosphatase activity	HBS1L ABCA2 ABCA3 ABCA4 TDRD9 DNAH10 DNAH2 MORC4 ABCA7 SEPTIN6 SEPTIN14 NAV3 KIF14 RAB37 DNAH9	2.21e-03	775	167	15	GO:0017111
GeneOntologyMolecularFunction	protein-disulfide reductase (NAD(P)H) activity	TXNRD2 TXNRD1	2.41e-03	9	167	2	GO:0047134
GeneOntologyBiologicalProcess	tricarboxylic acid cycle	ACO1 IREB2 SUCLG2 SUCLG1 SDHA	8.74e-06	35	167	5	GO:0006099
GeneOntologyBiologicalProcess	protein autophosphorylation	CAD RIPK1 MARK3 GRK7 DAPK2 IRAK1 DAPK1 DAPK3 EGFR MAP2K2	1.74e-05	228	167	10	GO:0046777
GeneOntologyBiologicalProcess	peptidyl-serine autophosphorylation	RIPK1 MARK3 MAP2K2	4.23e-05	9	167	3	GO:0036289
GeneOntologyBiologicalProcess	multi-pass transmembrane protein insertion into ER membrane	NOMO1 NOMO2 NOMO3	4.23e-05	9	167	3	GO:0160063
GeneOntologyBiologicalProcess	succinate metabolic process	SUCLG2 SUCLG1 SDHA	4.23e-05	9	167	3	GO:0006105
GeneOntologyBiologicalProcess	glycerol-3-phosphate catabolic process	GPD1 GPD1L	6.52e-05	2	167	2	GO:0046168
GeneOntologyCellularComponent	multi-pass translocon complex	NOMO1 NOMO2 NOMO3	4.13e-05	9	168	3	GO:0160064
GeneOntologyCellularComponent	succinate-CoA ligase complex (GDP-forming)	SUCLG2 SUCLG1	6.42e-05	2	168	2	GO:0045244
GeneOntologyCellularComponent	ER membrane insertion complex	NOMO1 NOMO2 NOMO3	1.74e-04	14	168	3	GO:0072379
GeneOntologyCellularComponent	succinate-CoA ligase complex	SUCLG2 SUCLG1	1.92e-04	3	168	2	GO:0042709
GeneOntologyCellularComponent	glycerol-3-phosphate dehydrogenase (FAD) complex	GPD1 GPD1L	1.92e-04	3	168	2	GO:0009331
MousePheno	asymmetric snout	HBS1L FREM1 EGFR	8.12e-06	5	132	3	MP:0008862
Domain	EGF-like_CS	RELN STAB2 ADAM9 F9 SVEP1 CRB1 CRELD1 PROZ EPHA2 SLIT1 WIF1 C6 C7	6.21e-07	261	166	13	IPR013032
Domain	DAPK1	DAPK2 DAPK1 DAPK3	6.90e-07	3	166	3	IPR020676
Domain	EGF_2	RELN STAB2 ADAM9 F9 SVEP1 CRB1 CRELD1 PROZ EPHA2 SLIT1 WIF1 C6 C7	7.38e-07	265	166	13	PS01186
Domain	EGF_3	RELN STAB2 ADAM9 F9 SVEP1 CRB1 CRELD1 PROZ SLIT1 WIF1 C6 C7	1.31e-06	235	166	12	PS50026
Domain	EGF-like_dom	RELN STAB2 ADAM9 F9 SVEP1 CRB1 CRELD1 PROZ SLIT1 WIF1 C6 C7	2.40e-06	249	166	12	IPR000742
Domain	DUF2012	NOMO1 NOMO2 NOMO3	2.74e-06	4	166	3	PF09430
Domain	DUF2012	NOMO1 NOMO2 NOMO3	2.74e-06	4	166	3	IPR019008
Domain	ABC_A	ABCA2 ABCA3 ABCA4 ABCA7	2.82e-06	12	166	4	IPR026082
Domain	EGF_1	RELN STAB2 ADAM9 F9 SVEP1 CRB1 CRELD1 PROZ SLIT1 WIF1 C6 C7	3.07e-06	255	166	12	PS00022
Domain	Kinase-like_dom	TLK2 ERBB2 RIPK1 WEE1 MARK3 GRK7 DAPK2 PAK5 IRAK1 DAPK1 DAPK3 EGFR PIK3CB CSNK1G2 EPHA2 PRKDC MAP2K2	7.00e-06	542	166	17	IPR011009
Domain	Protein_kinase_ATP_BS	TLK2 ERBB2 WEE1 MARK3 GRK7 DAPK2 PAK5 IRAK1 DAPK1 DAPK3 EGFR CSNK1G2 EPHA2 MAP2K2	7.65e-06	379	166	14	IPR017441
Domain	Growth_fac_rcpt_	ERBB2 STAB2 SVEP1 CRB1 CCN4 CRELD1 EGFR EPHA2 SLIT1	1.09e-05	156	166	9	IPR009030
Domain	6-PGluconate_DH_C-like	GPD1 GPD1L EHHADH UGDH	2.10e-05	19	166	4	IPR008927
Domain	Prot_kinase_dom	TLK2 ERBB2 RIPK1 WEE1 MARK3 GRK7 DAPK2 PAK5 IRAK1 DAPK1 DAPK3 EGFR CSNK1G2 EPHA2 MAP2K2	3.21e-05	489	166	15	IPR000719
Domain	PROTEIN_KINASE_DOM	TLK2 ERBB2 RIPK1 WEE1 MARK3 GRK7 DAPK2 PAK5 IRAK1 DAPK1 DAPK3 EGFR CSNK1G2 EPHA2 MAP2K2	3.53e-05	493	166	15	PS50011
Domain	DHC_N1	DNAH10 DNAH2 DNAH9	3.74e-05	8	166	3	PF08385
Domain	Carb-bd-like_fold	NOMO1 NOMO2 NOMO3	3.74e-05	8	166	3	IPR013784
Domain	Dynein_heavy_dom-1	DNAH10 DNAH2 DNAH9	3.74e-05	8	166	3	IPR013594
Domain	AAA	ABCA2 ABCA3 ABCA4 DNAH10 DNAH2 ABCA7 NAV3 DNAH9	4.44e-05	144	166	8	SM00382
Domain	AAA+_ATPase	ABCA2 ABCA3 ABCA4 DNAH10 DNAH2 ABCA7 NAV3 DNAH9	4.44e-05	144	166	8	IPR003593
Domain	EGF	RELN STAB2 ADAM9 F9 SVEP1 CRB1 CRELD1 PROZ SLIT1 WIF1	4.92e-05	235	166	10	SM00181
Domain	PROTEIN_KINASE_ATP	TLK2 ERBB2 WEE1 MARK3 GRK7 DAPK2 PAK5 IRAK1 DAPK1 DAPK3 EGFR CSNK1G2 EPHA2 MAP2K2	6.32e-05	459	166	14	PS00107
Domain	NAD_Gly3P_dh_C	GPD1 GPD1L	7.85e-05	2	166	2	PF07479
Domain	NAD_G3PDH	GPD1 GPD1L	7.85e-05	2	166	2	PS00957
Domain	Aconitase/IRP2	ACO1 IREB2	7.85e-05	2	166	2	IPR006249
Domain	G3P_DH_NAD-dep_C	GPD1 GPD1L	7.85e-05	2	166	2	IPR006109
Domain	G3P_DH_NAD-dep_N	GPD1 GPD1L	7.85e-05	2	166	2	IPR011128
Domain	NAD_Gly3P_dh_N	GPD1 GPD1L	7.85e-05	2	166	2	PF01210
Domain	G3P_DH_NAD-dep	GPD1 GPD1L	7.85e-05	2	166	2	IPR006168
Domain	G3P_DH_NAD-dep_euk	GPD1 GPD1L	7.85e-05	2	166	2	IPR017751
Domain	6PGD_dom_2	GPD1 GPD1L EHHADH	7.90e-05	10	166	3	IPR013328
Domain	-	GPD1 GPD1L EHHADH	7.90e-05	10	166	3	1.10.1040.10
Domain	Ser/Thr_kinase_AS	TLK2 RIPK1 WEE1 MARK3 GRK7 DAPK2 PAK5 IRAK1 DAPK1 DAPK3 CSNK1G2 MAP2K2	8.63e-05	357	166	12	IPR008271
Domain	S_TKc	TLK2 RIPK1 WEE1 MARK3 GRK7 DAPK2 PAK5 IRAK1 DAPK1 DAPK3 CSNK1G2 MAP2K2	9.10e-05	359	166	12	SM00220
Domain	PROTEIN_KINASE_ST	TLK2 RIPK1 WEE1 MARK3 GRK7 DAPK2 PAK5 IRAK1 DAPK1 DAPK3 CSNK1G2 MAP2K2	9.84e-05	362	166	12	PS00108
Domain	hEGF	SVEP1 CRB1 SLIT1 WIF1	1.04e-04	28	166	4	PF12661
Domain	EGF_CA	STAB2 F9 SVEP1 CRB1 CRELD1 PROZ SLIT1	1.10e-04	122	166	7	SM00179
Domain	EGF-like_Ca-bd_dom	STAB2 F9 SVEP1 CRB1 CRELD1 PROZ SLIT1	1.22e-04	124	166	7	IPR001881
Domain	EGF	STAB2 F9 SVEP1 CRB1 PROZ SLIT1 WIF1	1.34e-04	126	166	7	PF00008
Domain	Pkinase	TLK2 RIPK1 WEE1 MARK3 GRK7 DAPK2 PAK5 IRAK1 DAPK1 DAPK3 CSNK1G2 MAP2K2	1.59e-04	381	166	12	PF00069
Domain	CarboxyPept_regulatory_dom	NOMO1 NOMO2 NOMO3	1.85e-04	13	166	3	IPR014766
Domain	-	NOMO1 NOMO2 NOMO3	1.85e-04	13	166	3	2.60.40.1120
Domain	EGF_extracell	RELN STAB2 ADAM9 SVEP1 WIF1	1.92e-04	60	166	5	IPR013111
Domain	EGF_2	RELN STAB2 ADAM9 SVEP1 WIF1	1.92e-04	60	166	5	PF07974
Domain	WD_REPEATS_1	EML4 DTL CFAP43 WDR76 WDR75 WDCP NBEAL2 WDR35 WDR73 HERC2	1.97e-04	278	166	10	PS00678
Domain	WD_REPEATS_2	EML4 DTL CFAP43 WDR76 WDR75 WDCP NBEAL2 WDR35 WDR73 HERC2	2.02e-04	279	166	10	PS50082
Domain	WD_REPEATS_REGION	EML4 DTL CFAP43 WDR76 WDR75 WDCP NBEAL2 WDR35 WDR73 HERC2	2.02e-04	279	166	10	PS50294
Domain	Dynein_heavy_chain_D4_dom	DNAH10 DNAH2 DNAH9	2.34e-04	14	166	3	IPR024317
Domain	Dynein_HC_stalk	DNAH10 DNAH2 DNAH9	2.34e-04	14	166	3	IPR024743
Domain	Dynein_heavy_dom-2	DNAH10 DNAH2 DNAH9	2.34e-04	14	166	3	IPR013602
Domain	DHC_N2	DNAH10 DNAH2 DNAH9	2.34e-04	14	166	3	PF08393
Domain	ATPase_dyneun-rel_AAA	DNAH10 DNAH2 DNAH9	2.34e-04	14	166	3	IPR011704
Domain	MT	DNAH10 DNAH2 DNAH9	2.34e-04	14	166	3	PF12777
Domain	AAA_8	DNAH10 DNAH2 DNAH9	2.34e-04	14	166	3	PF12780
Domain	AAA_5	DNAH10 DNAH2 DNAH9	2.34e-04	14	166	3	PF07728
Domain	PFKB_KINASES_2	RBKS ADK	2.34e-04	3	166	2	PS00584
Domain	AconitaseA/IPMdHydase_ssu_swvl	ACO1 IREB2	2.34e-04	3	166	2	IPR000573
Domain	Aconitase_C	ACO1 IREB2	2.34e-04	3	166	2	PF00694
Domain	-	ACO1 IREB2	2.34e-04	3	166	2	3.30.499.10
Domain	Thioredoxin/glutathione_Rdtase	TXNRD2 TXNRD1	2.34e-04	3	166	2	IPR006338
Domain	Carboh/pur_kinase_PfkB_CS	RBKS ADK	2.34e-04	3	166	2	IPR002173
Domain	Acoase/IPM_deHydtase_lsu_aba	ACO1 IREB2	2.34e-04	3	166	2	IPR001030
Domain	-	ACO1 IREB2	2.34e-04	3	166	2	3.40.1060.10
Domain	-	ACO1 IREB2	2.34e-04	3	166	2	3.20.19.10
Domain	Acoase/IPM_deHydtase	ACO1 IREB2	2.34e-04	3	166	2	IPR015937
Domain	Acnase/IPM_dHydase_lsu_aba_1/3	ACO1 IREB2	2.34e-04	3	166	2	IPR015931
Domain	Aconitase/IPMdHydase_lsu_aba_2	ACO1 IREB2	2.34e-04	3	166	2	IPR015932
Domain	ACONITASE_1	ACO1 IREB2	2.34e-04	3	166	2	PS00450
Domain	Aconitase/3IPM_dehydase_swvl	ACO1 IREB2	2.34e-04	3	166	2	IPR015928
Domain	Aconitase	ACO1 IREB2	2.34e-04	3	166	2	PF00330
Domain	Aconitase_4Fe-4S_BS	ACO1 IREB2	2.34e-04	3	166	2	IPR018136
Domain	ACONITASE_2	ACO1 IREB2	2.34e-04	3	166	2	PS01244
Domain	DHC_fam	DNAH10 DNAH2 DNAH9	2.90e-04	15	166	3	IPR026983
Domain	Dynein_heavy	DNAH10 DNAH2 DNAH9	2.90e-04	15	166	3	PF03028
Domain	Dynein_heavy_dom	DNAH10 DNAH2 DNAH9	2.90e-04	15	166	3	IPR004273
Domain	EGF-type_Asp/Asn_hydroxyl_site	F9 SVEP1 CRB1 CRELD1 PROZ SLIT1	3.69e-04	106	166	6	IPR000152
Domain	CarboxyPept-like_regulatory	NOMO1 NOMO2 NOMO3	4.28e-04	17	166	3	IPR008969
Domain	CoA_ligase	SUCLG2 SUCLG1	4.66e-04	4	166	2	IPR005811
Domain	FacI_MAC	C6 C7	4.66e-04	4	166	2	IPR003884
Domain	PfkB_dom	RBKS ADK	4.66e-04	4	166	2	IPR011611
Domain	Succinyl-CoA_synth-like	SUCLG2 SUCLG1	4.66e-04	4	166	2	IPR016102
Domain	Ligase_CoA	SUCLG2 SUCLG1	4.66e-04	4	166	2	PF00549
Domain	PfkB	RBKS ADK	4.66e-04	4	166	2	PF00294
Domain	Tyr_kinase_EGF/ERB/XmrK_rcpt	ERBB2 EGFR	4.66e-04	4	166	2	IPR016245
Domain	FIMAC	C6 C7	4.66e-04	4	166	2	SM00057
Domain	-	SUCLG2 SUCLG1	4.66e-04	4	166	2	3.40.50.261
Domain	Furin_repeat	ERBB2 CRELD1 EGFR	5.10e-04	18	166	3	IPR006212
Domain	FU	ERBB2 CRELD1 EGFR	5.10e-04	18	166	3	SM00261
Domain	ABC_transporter_CS	ABCA2 ABCA3 ABCA4 ABCA7	5.18e-04	42	166	4	IPR017871
Domain	Cadherin_C	PCDHGB3 PCDHB8 PCDHB7 PCDHB2	5.18e-04	42	166	4	IPR032455
Domain	Cadherin_C_2	PCDHGB3 PCDHB8 PCDHB7 PCDHB2	5.18e-04	42	166	4	PF16492
Domain	Peptidase_S1A	PRSS3 TMPRSS12 F9 PROZ GZMA TMPRSS3	5.19e-04	113	166	6	IPR001314
Domain	TRYPSIN_DOM	PRSS3 TMPRSS12 F9 PROZ GZMA TMPRSS3	5.70e-04	115	166	6	PS50240
Domain	Tryp_SPc	PRSS3 TMPRSS12 F9 PROZ GZMA TMPRSS3	6.25e-04	117	166	6	SM00020
Domain	Trypsin_dom	PRSS3 TMPRSS12 F9 PROZ GZMA TMPRSS3	7.45e-04	121	166	6	IPR001254
Domain	Trypsin	PRSS3 TMPRSS12 F9 PROZ GZMA TMPRSS3	7.45e-04	121	166	6	PF00089
Domain	WD40_repeat	EML4 DTL CFAP43 WDR76 WDR75 NBEAL2 WDR35 WDR73 HERC2	7.48e-04	272	166	9	IPR001680
Domain	Pyr_OxRdtase_I_AS	TXNRD2 TXNRD1	7.72e-04	5	166	2	IPR012999
Domain	Pyr_redox_dim	TXNRD2 TXNRD1	7.72e-04	5	166	2	PF02852
Domain	PYRIDINE_REDOX_1	TXNRD2 TXNRD1	7.72e-04	5	166	2	PS00076
Pathway	WP_BLADDER_CANCER	ERBB2 DAPK2 DAPK1 DAPK3 EGFR MAP2K2	1.42e-06	40	127	6	M39523
Pathway	KEGG_BLADDER_CANCER	ERBB2 DAPK2 DAPK1 DAPK3 EGFR MAP2K2	1.91e-06	42	127	6	M19096
Pathway	REACTOME_CASPASE_ACTIVATION_VIA_EXTRINSIC_APOPTOTIC_SIGNALLING_PATHWAY	RIPK1 DAPK2 DAPK1 DAPK3	8.05e-05	26	127	4	M27434
Pathway	REACTOME_CASPASE_ACTIVATION_VIA_DEPENDENCE_RECEPTORS_IN_THE_ABSENCE_OF_LIGAND	DAPK2 DAPK1 DAPK3	8.18e-05	10	127	3	M866
Pathway	KEGG_MEDICUS_REFERENCE_CITRATE_CYCLE_SECOND_CARBON_OXIDATION_2	SUCLG2 SUCLG1 SDHA	8.18e-05	10	127	3	M47942
Pathway	KEGG_MEDICUS_VARIANT_ERBB2_OVEREXPRESSION_TO_PI3K_SIGNALING_PATHWAY	ERBB2 EGFR PIK3CB	1.48e-04	12	127	3	M47393
Pathway	KEGG_CITRATE_CYCLE_TCA_CYCLE	ACO1 SUCLG2 SUCLG1 SDHA	1.64e-04	31	127	4	M3985
Pubmed	Recurrent NOMO1 Gene Deletion Is a Potential Clinical Marker in Early-Onset Colorectal Cancer and Is Involved in the Regulation of Cell Migration.	NOMO1 NOMO2 NOMO3	1.11e-07	3	168	3	36011023
Pubmed	The death-associated protein kinases: structure, function, and beyond.	DAPK2 DAPK1 DAPK3	1.11e-07	3	168	3	16756490
Pubmed	Silencing of nodal modulator 1 inhibits the differentiation of P19 cells into cardiomyocytes.	NOMO1 NOMO2 NOMO3	1.11e-07	3	168	3	25576386
Pubmed	Clinicopathologic features of non-small-cell lung cancer with EML4-ALK fusion gene.	ERBB2 EML4 EGFR	4.41e-07	4	168	3	20183914
Pubmed	Establishment of a conditional Nomo1 mouse model by CRISPR/Cas9 technology.	NOMO1 NOMO2 NOMO3	4.41e-07	4	168	3	31833031
Pubmed	A locus for autosomal recessive pseudoxanthoma elasticum, with penetrance of vascular symptoms in carriers, maps to chromosome 16p13.1.	NOMO1 NOMO2 NOMO3	4.41e-07	4	168	3	9267806
Pubmed	Genomic analysis of mouse retinal development.	ABCA2 FZD3 SEM1 MARK3 EML4 ESD DUSP8 SKIL CRHBP NOMO1 FAM120A NOMO2 SV2B SLIT1 NAV3 UTP20 PRKDC FOXK1 NOMO3	4.64e-07	1006	168	19	15226823
Pubmed	Multiplexed kinase interactome profiling quantifies cellular network activity and plasticity.	TLK2 RIPK1 WEE1 MARK3 EML4 PAK5 IRAK1 GRIA2 DAPK3 MPRIP NOMO1 EGFR NOMO2 EPHA2 MAP2K2 FOXK1 NOMO3 FAM83A	4.89e-07	910	168	18	36736316
Pubmed	HERC2 targets the iron regulator FBXL5 for degradation and modulates iron metabolism.	ACO1 IREB2 HERC2	2.19e-06	6	168	3	24778179
Pubmed	The human and murine protocadherin-beta one-exon gene families show high evolutionary conservation, despite the difference in gene number.	PCDHB8 PCDHB7 PCDHB2 PCDHB18P	2.40e-06	20	168	4	11322959
Pubmed	Stretch-induced fetal type II cell differentiation is mediated via ErbB1-ErbB4 interactions.	ERBB2 ABCA3 EGFR	3.82e-06	7	168	3	22493501
Pubmed	Endogenous β-glucocerebrosidase activity in Abca12⁻/⁻epidermis elevates ceramide levels after topical lipid application but does not restore barrier function.	ABCA2 ABCA3 ABCA7	6.09e-06	8	168	3	24293640
Pubmed	Cytoarchitecture of the olfactory bulb in the laggard mutant mouse.	RELN NCAM1 KIF14	6.09e-06	8	168	3	24931760
Pubmed	Nicalin and its binding partner Nomo are novel Nodal signaling antagonists.	NOMO1 NOMO2 NOMO3	6.09e-06	8	168	3	15257293
Pubmed	A dual-activity topoisomerase complex regulates mRNA translation and turnover.	PNPLA2 ERBB2 ABCA2 SZT2 IRAK1 CFAP43 TXNRD2 ABCA7 ANO8 MPRIP CSNK1G2 NBEAL2 SCN5A NFX1 PRKDC HERC2 FOXK1 SDHA	7.40e-06	1105	168	18	35748872
Pubmed	Clustered gamma-protocadherins regulate cortical interneuron programmed cell death.	RELN PCDHB8 PCDHB7 PCDHB2 PCDHB18P	8.47e-06	57	168	5	32633719
Pubmed	Synergistic drug combinations for cancer identified in a CRISPR screen for pairwise genetic interactions.	ERBB2 SLC39A3 DAPK3 EGFR PIK3CB CSNK1G2 EPHA2 PRKDC MAP2K2	8.63e-06	276	168	9	28319085
Pubmed	Redox DAPK1 destabilizes Pellino1 to govern inflammation-coupling tubular damage during septic AKI.	RIPK1 IRAK1 DAPK1	9.10e-06	9	168	3	33052227
Pubmed	Substrate-driven assembly of a translocon for multipass membrane proteins.	NOMO1 NOMO2 NOMO3	9.10e-06	9	168	3	36261522
Pubmed	CTCF Governs the Identity and Migration of MGE-Derived Cortical Interneurons.	RELN PCDHB8 PCDHB7 PCDHB2 PCDHB18P	9.23e-06	58	168	5	30377227
Pubmed	The Deubiquitinating Enzyme USP48 Interacts with the Retinal Degeneration-Associated Proteins UNC119a and ARL3.	PSAT1 ABCA4 ESD NCAM1 SUCLG1 NOMO1 FAM120A NOMO2 SV2B ELAVL1 NOMO3 SDHA	1.70e-05	552	168	12	36293380
Pubmed	An ER translocon for multi-pass membrane protein biogenesis.	NOMO1 NOMO2 NOMO3	1.78e-05	11	168	3	32820719
Pubmed	Comparative DNA sequence analysis of mouse and human protocadherin gene clusters.	PCDHGB3 PCDHB8 PCDHB7 PCDHB2 PCDHB18P	2.02e-05	68	168	5	11230163
Pubmed	A central chaperone-like role for 14-3-3 proteins in human cells.	ERBB2 WEE1 MARK3 GRK7 DAPK2 PAK5 DTL DAPK3 MPRIP IVNS1ABP KIF14 MAP2K2 GARRE1 FOXK1 MTSS2	2.05e-05	861	168	15	36931259
Pubmed	Prognostic and predictive values of EGFR overexpression and EGFR copy number alteration in HER2-positive breast cancer.	ERBB2 EGFR	2.32e-05	2	168	2	25349977
Pubmed	Molecular analysis of ABCA4 and CRB1 genes in a Spanish family segregating both Stargardt disease and autosomal recessive retinitis pigmentosa.	ABCA4 CRB1	2.32e-05	2	168	2	18334942
Pubmed	Prognostic role of human epidermal growth factor receptor in gastric cancer: a systematic review and meta-analysis.	ERBB2 EGFR	2.32e-05	2	168	2	23871709
Pubmed	A regulated RNA binding protein also possesses aconitase activity.	ACO1 IREB2	2.32e-05	2	168	2	1946430
Pubmed	Genetic ablations of iron regulatory proteins 1 and 2 reveal why iron regulatory protein 2 dominates iron homeostasis.	ACO1 IREB2	2.32e-05	2	168	2	14726953
Pubmed	HER1 R497K and HER2 I655V polymorphisms are linked to development of breast cancer.	ERBB2 EGFR	2.32e-05	2	168	2	23594562
Pubmed	Identification of autophosphorylation sites of HER2/neu.	ERBB2 EGFR	2.32e-05	2	168	2	1706616
Pubmed	Effect of hypoxia on the binding and subcellular distribution of iron regulatory proteins.	ACO1 IREB2	2.32e-05	2	168	2	17200797
Pubmed	Effects of the combined blockade of EGFR and ErbB-2 on signal transduction and regulation of cell cycle regulatory proteins in breast cancer cells.	ERBB2 EGFR	2.32e-05	2	168	2	19946741
Pubmed	EGFR and ERBB2 Exon 20 Insertion Mutations in Chinese Non-small Cell Lung Cancer Patients: Pathological and Molecular Characterization, and First-Line Systemic Treatment Evaluation.	ERBB2 EGFR	2.32e-05	2	168	2	38416376
Pubmed	Evolutionary analysis of the ErbB receptor and ligand families.	ERBB2 EGFR	2.32e-05	2	168	2	10824084
Pubmed	Synergistic Blockade of EGFR and HER2 by New-Generation EGFR Tyrosine Kinase Inhibitor Enhances Radiation Effect in Bladder Cancer Cells.	ERBB2 EGFR	2.32e-05	2	168	2	25589492
Pubmed	Protein overexpression and gene amplification of HER-2 and EGFR in colorectal cancers: an immunohistochemical and fluorescent in situ hybridization study.	ERBB2 EGFR	2.32e-05	2	168	2	15143334
Pubmed	Impact of common epidermal growth factor receptor and HER2 variants on receptor activity and inhibition by lapatinib.	ERBB2 EGFR	2.32e-05	2	168	2	18199554
Pubmed	HuR-mediated SCN5A messenger RNA stability reduces arrhythmic risk in heart failure.	SCN5A ELAVL1	2.32e-05	2	168	2	29454929
Pubmed	In vivo role(s) of the iron regulatory proteins (IRP) 1 and 2 in aseptic local inflammation.	ACO1 IREB2	2.32e-05	2	168	2	19533074
Pubmed	Microcytic anemia, erythropoietic protoporphyria, and neurodegeneration in mice with targeted deletion of iron-regulatory protein 2.	ACO1 IREB2	2.32e-05	2	168	2	15831703
Pubmed	Expression of erbB-1 and erbB-2 genes in normal and pathological human endometrium.	ERBB2 EGFR	2.32e-05	2	168	2	17549377
Pubmed	The efficient elimination of solid tumor cells by EGFR-specific and HER2-specific scFv-SNAP fusion proteins conjugated to benzylguanine-modified auristatin F.	ERBB2 EGFR	2.32e-05	2	168	2	27502168
Pubmed	Attenuation of EPO-dependent erythroblast formation by death-associated protein kinase-2.	DAPK2 DAPK1	2.32e-05	2	168	2	18535204
Pubmed	Frequent genetic alterations in EGFR- and HER2-driven pathways in breast cancer brain metastases.	ERBB2 EGFR	2.32e-05	2	168	2	23665199
Pubmed	Epidermal growth factor receptor activity is necessary for mouse basal cell proliferation.	ERBB2 EGFR	2.32e-05	2	168	2	25217659
Pubmed	Iron misregulation and neurodegenerative disease in mouse models that lack iron regulatory proteins.	ACO1 IREB2	2.32e-05	2	168	2	25771171
Pubmed	EGFR and HER2 expression in advanced biliary tract cancer.	ERBB2 EGFR	2.32e-05	2	168	2	19777609
Pubmed	Characterization of a second RNA-binding protein in rodents with specificity for iron-responsive elements.	ACO1 IREB2	2.32e-05	2	168	2	8262972
Pubmed	Increased concentrations of growth factors and activation of the EGFR system in breast cancer.	ERBB2 EGFR	2.32e-05	2	168	2	23089711
Pubmed	EGFR Expression in HER2-Driven Breast Cancer Cells.	ERBB2 EGFR	2.32e-05	2	168	2	33260837
Pubmed	The immune microenvironment in EGFR- and ERBB2-mutated lung adenocarcinoma.	ERBB2 EGFR	2.32e-05	2	168	2	34487971
Pubmed	Screening and validation of dinucleotide repeats in intron 1 of the human EGFR gene and its paralog in the HER2 gene.	ERBB2 EGFR	2.32e-05	2	168	2	18946768
Pubmed	The receptor tyrosine kinase EphA2 promotes mammary adenocarcinoma tumorigenesis and metastatic progression in mice by amplifying ErbB2 signaling.	ERBB2 EPHA2	2.32e-05	2	168	2	18079969
Pubmed	Design, biological evaluation and 3D QSAR studies of novel dioxin-containing pyrazoline derivatives with thiourea skeleton as selective HER-2 inhibitors.	ERBB2 EGFR	2.32e-05	2	168	2	27273260
Pubmed	Iron regulatory proteins 1 and 2 in human monocytes, macrophages and duodenum: expression and regulation in hereditary hemochromatosis and iron deficiency.	ACO1 IREB2	2.32e-05	2	168	2	16503547
Pubmed	Self-association and ligand-induced conformational changes of iron regulatory proteins 1 and 2.	ACO1 IREB2	2.32e-05	2	168	2	15938636
Pubmed	Induction of cancer cell migration by epidermal growth factor is initiated by specific phosphorylation of tyrosine 1248 of c-erbB-2 receptor via EGFR.	ERBB2 EGFR	2.32e-05	2	168	2	12354693
Pubmed	Fluorescence-Raman dual modal endoscopic system for multiplexed molecular diagnostics.	ERBB2 EGFR	2.32e-05	2	168	2	25820115
Pubmed	Expression of EGFR, Her2 predict lymph node metastasis (LNM)-associated metastasis in colorectal cancer.	ERBB2 EGFR	2.32e-05	2	168	2	23220854
Pubmed	Cell adhesion and EGFR activation regulate EphA2 expression in cancer.	EGFR EPHA2	2.32e-05	2	168	2	19948216
Pubmed	Cloning of the cDNA encoding an RNA regulatory protein--the human iron-responsive element-binding protein.	ACO1 IREB2	2.32e-05	2	168	2	2172968
Pubmed	Gangliosides influence EGFR/ErbB2 heterodimer stability but they do not modify EGF-dependent ErbB2 phosphorylation.	ERBB2 EGFR	2.32e-05	2	168	2	20156584
Pubmed	EGFR and HER-2 oncogenes expression in an experimental model of two-stage chemically induced carcinogenesis in mouse skin.	ERBB2 EGFR	2.32e-05	2	168	2	38443188
Pubmed	Differential spatial expression and activation pattern of EGFR and HER2 in human breast cancer.	ERBB2 EGFR	2.32e-05	2	168	2	17611648
Pubmed	No association of DAPK1 and ABCA2 SNPs on chromosome 9 with Alzheimer's disease.	ABCA2 DAPK1	2.32e-05	2	168	2	18336955
Pubmed	Linkage between complement components 6 and 7 and glutamic pyruvate transaminase in the marsupial Monodelphis domestica.	C6 C7	2.32e-05	2	168	2	8259924
Pubmed	The ADAM9/WISP-1 axis cooperates with osteoblasts to stimulate primary prostate tumor growth and metastasis.	ADAM9 CCN4	2.32e-05	2	168	2	36778124
Pubmed	A novel dual EGFR/HER2 inhibitor KU004 induces cell cycle arrest and apoptosis in HER2-overexpressing cancer cells.	ERBB2 EGFR	2.32e-05	2	168	2	26437915
Pubmed	EGFR and HER2 receptor kinase signaling mediate epithelial cell invasion by Candida albicans during oropharyngeal infection.	ERBB2 EGFR	2.32e-05	2	168	2	22891338
Pubmed	Expression of epidermal growth factor receptor and HER-2 in pediatric embryonal brain tumors.	ERBB2 EGFR	2.32e-05	2	168	2	20962551
Pubmed	Structural and energetic basis for the molecular recognition of dual synthetic vs. natural inhibitors of EGFR/HER2.	ERBB2 EGFR	2.32e-05	2	168	2	29329808
Pubmed	Dual-Receptor-Targeted (DRT) Radiation Nanomedicine Labeled with 177Lu Is More Potent for Killing Human Breast Cancer Cells That Coexpress HER2 and EGFR Than Single-Receptor-Targeted (SRT) Radiation Nanomedicines.	ERBB2 EGFR	2.32e-05	2	168	2	32022567
Pubmed	Comparative analysis of fluorescence resonance energy transfer (FRET) and proximity ligation assay (PLA).	ERBB2 EGFR	2.32e-05	2	168	2	21480528
Pubmed	Targeting EGFR/HER2 pathways enhances the antiproliferative effect of gemcitabine in biliary tract and gallbladder carcinomas.	ERBB2 EGFR	2.32e-05	2	168	2	21087480
Pubmed	A Comparison of Immunohistochemical Expression of Epidermal Growth Factor Receptor and Human Epidermal Growth Factor Receptor 2 in Dental Follicles with Different Radiographic Sizes.	ERBB2 EGFR	2.32e-05	2	168	2	39205824
Pubmed	Lapatinib, a dual inhibitor of ErbB-1/-2 receptors, enhances effects of combination chemotherapy in bladder cancer cells.	ERBB2 EGFR	2.32e-05	2	168	2	19287975
Pubmed	The signaling and transformation potency of the overexpressed HER2 protein is dependent on the normally-expressed EGFR.	ERBB2 EGFR	2.32e-05	2	168	2	21911055
Pubmed	Resolution of oxidative stress by thioredoxin reductase: Cysteine versus selenocysteine.	TXNRD2 TXNRD1	2.32e-05	2	168	2	24624337
Pubmed	Detection of EGFR mutations and EML4-ALK rearrangements in lung adenocarcinomas using archived cytological slides.	EML4 EGFR	2.32e-05	2	168	2	23408463
Pubmed	Specialized functions of Nav1.5 and Nav1.9 channels in electrogenesis of myenteric neurons in intact mouse ganglia.	SCN11A SCN5A	2.32e-05	2	168	2	24719102
Pubmed	HuR-dependent expression of Wisp1 is necessary for TGFβ-induced cardiac myofibroblast activity.	CCN4 ELAVL1	2.32e-05	2	168	2	36372279
Pubmed	EGF-mediated inhibition of ubiquitin-specific peptidase 24 expression has a crucial role in tumorigenesis.	USP24 EGFR	2.32e-05	2	168	2	27991932
Pubmed	Elevated levels of epidermal growth factor receptor/c-erbB2 heterodimers mediate an autocrine growth regulatory pathway in tamoxifen-resistant MCF-7 cells.	ERBB2 EGFR	2.32e-05	2	168	2	12586780
Pubmed	Overexpression of Epidermal Growth Factor Receptor (EGFR) and HER-2 in Bladder Carcinoma and Its Association with Patients' Clinical Features.	ERBB2 EGFR	2.32e-05	2	168	2	30296252
Pubmed	EGFR and ERBB2 Germline Mutations in Chinese Lung Cancer Patients and Their Roles in Genetic Susceptibility to Cancer.	ERBB2 EGFR	2.32e-05	2	168	2	30610926
Pubmed	Novel mutations in CRB1 and ABCA4 genes cause Leber congenital amaurosis and Stargardt disease in a Swedish family.	ABCA4 CRB1	2.32e-05	2	168	2	23443024
Pubmed	EGFR negates the proliferative effect of oncogenic HER2 in MDA-MB-231 cells.	ERBB2 EGFR	2.32e-05	2	168	2	25935365
Pubmed	A physical map of the C6 and C7 complement component gene region on chromosome 5p13.	C6 C7	2.32e-05	2	168	2	8364540
Pubmed	Serum levels of epidermal growth factor and HER-2 neu in non small-cell lung cancer: prognostic correlation.	ERBB2 EGFR	2.32e-05	2	168	2	19093231
Pubmed	Circular HER2 RNA positive triple negative breast cancer is sensitive to Pertuzumab.	ERBB2 EGFR	2.32e-05	2	168	2	32917240
Pubmed	EGFR and erbB2 in malignant peripheral nerve sheath tumors and implications for targeted therapy.	ERBB2 EGFR	2.32e-05	2	168	2	18650488
Pubmed	Genomic activation of the EGFR and HER2-neu genes in a significant proportion of invasive epithelial ovarian cancers.	ERBB2 EGFR	2.32e-05	2	168	2	18182111
Pubmed	Correlations of EGFR mutations and increases in EGFR and HER2 copy number to gefitinib response in a retrospective analysis of lung cancer patients.	ERBB2 EGFR	2.32e-05	2	168	2	17626639
Pubmed	A diterpenoid derivate compound targets selenocysteine of thioredoxin reductases and induces Bax/Bak-independent apoptosis.	TXNRD2 TXNRD1	2.32e-05	2	168	2	23732520
Pubmed	Affinity-Tuned ErbB2 or EGFR Chimeric Antigen Receptor T Cells Exhibit an Increased Therapeutic Index against Tumors in Mice.	ERBB2 EGFR	2.32e-05	2	168	2	26330166
Pubmed	The Transmodulation of HER2 and EGFR by Substance P in Breast Cancer Cells Requires c-Src and Metalloproteinase Activation.	ERBB2 EGFR	2.32e-05	2	168	2	26114632
Pubmed	Assessment of HER1 (rs11543848) and HER2 (rs1136201) polymorphism and their association with colorectal cancer susceptibility in Khyber Pakhtunkhwa, Pakistan.	ERBB2 EGFR	2.32e-05	2	168	2	38040921
Pubmed	HER2 and EGFR amplification and expression in urothelial carcinoma occurs in distinct biological and molecular contexts.	ERBB2 EGFR	2.32e-05	2	168	2	28388586
Pubmed	Enhancement of chemosensitivity by WEE1 inhibition in EGFR-TKIs resistant non-small cell lung cancer.	WEE1 EGFR	2.32e-05	2	168	2	31387179
Interaction	PELI1 interactions	RIPK1 IRAK1 DAPK1 EGFR PRKDC HERC2	1.47e-05	65	164	6	int:PELI1
Interaction	EXOSC10 interactions	HBS1L OAS3 NOMO1 WDR75 EGFR NOMO2 NFX1 KIF14 UTP20 NOMO3	1.50e-05	223	164	10	int:EXOSC10
Interaction	CRKL interactions	ERBB2 MPZL1 AOX1 CLIC4 EGFR PIK3CB EPHA2 KIF14 ELAVL1 GARRE1	1.74e-05	227	164	10	int:CRKL
Interaction	PCDHB3 interactions	ABCA2 SLC39A3 PCDHB8 PCDHB7 PCDHB2 PCDHB18P EGFR ODR4	2.05e-05	141	164	8	int:PCDHB3
Cytoband	5q31	PCDHGB3 PCDHB8 PCDHB7 PCDHB2 PCDHB18P	6.86e-05	115	168	5	5q31
GeneFamily	ATP binding cassette subfamily A	ABCA2 ABCA3 ABCA4 ABCA7	9.89e-07	14	104	4	805
GeneFamily	Ankyrin repeat domain containing\|Death associated protein kinases	DAPK2 DAPK1 DAPK3	1.83e-06	5	104	3	1021
GeneFamily	Clustered protocadherins	PCDHGB3 PCDHB8 PCDHB7 PCDHB2 PCDHB18P	3.33e-05	64	104	5	20
GeneFamily	Dyneins, axonemal	DNAH10 DNAH2 DNAH9	1.19e-04	17	104	3	536
GeneFamily	WD repeat domain containing	EML4 DTL CFAP43 WDR76 WDR75 NBEAL2 WDR35 WDR73	1.36e-04	262	104	8	362
GeneFamily	Erb-b2 receptor tyrosine kinases	ERBB2 EGFR	1.95e-04	4	104	2	1096
GeneFamily	Hyalectan proteoglycans\|V-set domain containing\|Sushi domain containing\|C-type lectin domain containing	CSMD2 SVEP1 C6 C7	3.23e-04	57	104	4	1179
GeneFamily	Chloride intracellular channels	CLIC4 CLIC2	4.84e-04	6	104	2	307
GeneFamily	Sodium voltage-gated channel alpha subunits	SCN11A SCN5A	1.15e-03	9	104	2	1203
GeneFamily	Septins	SEPTIN6 SEPTIN14	2.45e-03	13	104	2	732
GeneFamily	Gla domain containing	F9 PROZ	2.45e-03	13	104	2	1250
GeneFamily	Proteases, serine	PRSS3 TMPRSS12 TMPRSS3	5.72e-03	63	104	3	738
ToppCell	droplet-Limb_Muscle-MUSCLE-30m-Mesenchymal-chondrocyte-like\|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	RIPK1 RNF19B CCDC80 SKIL TXNRD1 ADK CCN4 WIF1 C7	6.39e-08	197	168	9	cfd4cc5fb8d7a60dd5c0d2a1a7bad7ba38c19d40
ToppCell	facs-Marrow-B-cells-24m-Lymphocytic-precursor_B_cell\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	DNAH10 PAK5 PKHD1L1 SVEP1 FREM1 CRB1 TRPM8 DNAH9	1.76e-07	160	168	8	c381ec6be8cf887861cc18f831a20db42f953fe1
ToppCell	facs-Marrow-B-cells-24m-Lymphocytic-pre_B_cell\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	DNAH10 PAK5 PKHD1L1 SVEP1 FREM1 CRB1 TRPM8 DNAH9	1.76e-07	160	168	8	25c8f3d2a6d14ff0ca0b965fce89d3ff22f40585
ToppCell	droplet-Liver-HEPATOCYTES-1m-Epithelial\|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	GPD1 PSAT1 AOX1 F9 BDH1 EGFR EHHADH UGDH	2.56e-07	168	168	8	b98af4043dfa5dfa4413e482879fad88de484675
ToppCell	droplet-Liver-HEPATOCYTES-1m-Epithelial-hepatocyte\|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	GPD1 PSAT1 AOX1 F9 BDH1 EGFR EHHADH UGDH	2.56e-07	168	168	8	073b53d4cee6bc8c5c6fce51cf6cd9c316478f69
ToppCell	droplet-Liver-HEPATOCYTES\|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	GPD1 PSAT1 AOX1 F9 BDH1 EGFR EHHADH UGDH	2.68e-07	169	168	8	f195467438c589f87224bde7da720dea072d110c
ToppCell	droplet-Liver-HEPATOCYTES-1m\|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	GPD1 PSAT1 AOX1 F9 BDH1 EGFR EHHADH UGDH	2.68e-07	169	168	8	7785cab967a33560830c394c918d6ce625103858
ToppCell	5'-Parenchyma_lung-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.3.0\|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	DNAH10 ANKUB1 DNAH2 GRIA2 CFAP43 C6orf118 C6 DNAH9	4.15e-07	179	168	8	5e5f1cdf4aa66868d45b74ba91e20e848a3cbaff
ToppCell	facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-thymocyte\|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	RELN STAB2 ABCA4 DNAH10 PKHD1L1 FREM1 NAV3 DNAH9	5.11e-07	184	168	8	2cbed6462fea2622871bb7e49b0df3d984239281
ToppCell	facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-proliferating_thymocyte;_DN_to_DP_transition,_dividing_(some_are_Cd8+/_Cd4+,_some_undergoing_VDJ_recombination)\|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	RELN STAB2 ABCA4 DNAH10 PKHD1L1 FREM1 NAV3 DNAH9	5.11e-07	184	168	8	2b19a8c5f823e00812908b23e66bb4e563278aff
ToppCell	facs-Thymus-Thymus_Epithelium-18m-Lymphocytic\|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	RELN STAB2 ABCA4 DNAH10 PKHD1L1 FREM1 NAV3 DNAH9	5.11e-07	184	168	8	ea7a7e2bac46d4d2c31a5d576b38a032b5335062
ToppCell	Ciliated_cells-B-SSc-ILD_01\|World / lung cells shred on cell class, cell subclass, sample id	DNAH10 ANKUB1 DNAH2 CFAP43 AK7 C6orf118 C6 DNAH9	5.78e-07	187	168	8	2b4262c2e7c7830a976be168cee6eeb738d4feda
ToppCell	(7)_Epithelial-F_(Ciliated)\|World / Lung cell shreds - cell class (v4) and cell subclass (v4)	DNAH10 ANKUB1 DNAH2 CFAP43 AK7 C6orf118 C6 DNAH9	6.02e-07	188	168	8	9a8b9f745eed9f129b6c582f48fbbaaacbebb4b3
ToppCell	wk_15-18-Epithelial-Proximal_epithelial-MUC16+_ciliated\|wk_15-18 / Celltypes from embryonic and fetal-stage human lung	DNAH10 ANKUB1 DNAH2 CFAP43 AK7 C6orf118 C6 DNAH9	6.78e-07	191	168	8	e81cd65dbf0ef1c2ab7088f73ce605d456dd3a7a
ToppCell	LPS_only-Epithelial_alveolar-AT_1-Differentiating_AT2\|LPS_only / Treatment groups by lineage, cell group, cell type	ERBB2 ABCA3 STAB2 ABCA4 TDRD9 TXNRD2 ADK EGFR	8.56e-07	197	168	8	6b6504c47c309bac4f790e2f372d454bbdea49e8
ToppCell	distal-Epithelial-Ciliated-2\|distal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed)	DNAH10 ANKUB1 DNAH2 CFAP43 AK7 C6orf118 C6 DNAH9	9.24e-07	199	168	8	2de1fe124737a6cca4b3805ab3056f9d9d7c16c7
ToppCell	medial-Epithelial-Ciliated\|medial / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed)	DNAH10 ANKUB1 DNAH2 CFAP43 AK7 C6orf118 C6 DNAH9	9.24e-07	199	168	8	a2daa42b100c422dc8c04fb7d2ebf54293eef574
ToppCell	distal-Epithelial-Ciliated-3\|distal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed)	DNAH10 ANKUB1 DNAH2 CFAP43 AK7 C6orf118 C6 DNAH9	9.24e-07	199	168	8	6ce0df4a6f4d9353919e26ffab97c9ec89911da6
ToppCell	medial-Epithelial-Ciliated-2\|medial / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed)	DNAH10 ANKUB1 DNAH2 CFAP43 AK7 C6orf118 C6 DNAH9	9.24e-07	199	168	8	526002f16bbf61cf086278d45a401cc0b0b757a8
ToppCell	distal-Epithelial-Ciliated\|distal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed)	DNAH10 ANKUB1 DNAH2 CFAP43 AK7 C6orf118 C6 DNAH9	9.24e-07	199	168	8	18ca031cfe702afb9bf94e03c0f3680c38e7599e
ToppCell	medial-2-Epithelial-Ciliated\|2 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed)	DNAH10 ANKUB1 DNAH2 CFAP43 AK7 C6orf118 C6 DNAH9	9.24e-07	199	168	8	c02f04a5aa79ee0cf427f6e94b93ceab38ebbcd7
ToppCell	Bronchial-10x5prime-Epithelial-Epi_airway_ciliated-Ciliated\|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations	DNAH10 ANKUB1 DNAH2 CFAP43 AK7 C6orf118 C6 DNAH9	9.59e-07	200	168	8	55c148238d5c80c1faa3428a917ae8075be2c145
ToppCell	Biopsy_IPF-Epithelial-Ciliated\|Biopsy_IPF / Sample group, Lineage and Cell type	DNAH10 ANKUB1 DNAH2 CFAP43 AK7 C6orf118 C6 DNAH9	9.59e-07	200	168	8	bb8c99156e547a8eb6599b6b6bc3c66bf77af7f8
ToppCell	Biopsy_Control_(H.)-Epithelial-Ciliated\|Biopsy_Control_(H.) / Sample group, Lineage and Cell type	DNAH10 ANKUB1 DNAH2 CFAP43 AK7 C6orf118 C6 DNAH9	9.59e-07	200	168	8	9ae434c78e08adf95da49c85616e3ca72d1227bf
ToppCell	Bronchial-10x5prime-Epithelial-Epi_airway_ciliated\|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations	DNAH10 ANKUB1 DNAH2 CFAP43 AK7 C6orf118 C6 DNAH9	9.59e-07	200	168	8	52aef65f01b06cd98056f17977efe525aee6eb6f
ToppCell	LPS_IL1RA_TNF-Epithelial_airway-airway_epithelial-Ciliated\|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type	TDRD9 DNAH10 ANKUB1 DNAH2 AK7 C6orf118 SV2B DNAH9	9.59e-07	200	168	8	96701a4d57753f5ec0dd5c7550054bbcc946bc5f
ToppCell	Biopsy_Other_PF-Epithelial-Ciliated\|Biopsy_Other_PF / Sample group, Lineage and Cell type	DNAH10 ANKUB1 DNAH2 CFAP43 AK7 C6orf118 C6 DNAH9	9.59e-07	200	168	8	721371698bce8890853fb6b6b01a2c20293b39e9
ToppCell	Parenchymal-10x5prime-Epithelial-Epi_airway_ciliated\|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations	DNAH10 ANKUB1 DNAH2 CFAP43 AK7 C6orf118 C6 DNAH9	9.59e-07	200	168	8	85c98da55f7cd4ffdf9d309b56c8cc5d43f3c04c
ToppCell	Parenchymal-10x3prime_v2-Epithelial-Epi_airway_ciliated\|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations	DNAH10 ANKUB1 DNAH2 CFAP43 AK7 C6orf118 C6 DNAH9	9.59e-07	200	168	8	5abd6d81e1cc354484ae693fcd708d78926e75b5
ToppCell	Parenchymal-10x3prime_v2-Epithelial-Epi_airway_ciliated-Ciliated\|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations	DNAH10 ANKUB1 DNAH2 CFAP43 AK7 C6orf118 C6 DNAH9	9.59e-07	200	168	8	9c9d2b0276c7b0709c2eeeb0673a2f58106fb14e
ToppCell	Parenchymal-10x5prime-Epithelial-Epi_airway_ciliated-Ciliated\|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations	DNAH10 ANKUB1 DNAH2 CFAP43 AK7 C6orf118 C6 DNAH9	9.59e-07	200	168	8	12bc7d95c4166d12487081a76d210b7abe5991b0
ToppCell	(5)_Fibroblast-H\|World / Lung cell shreds - cell class (v4) and cell subclass (v4)	CPA4 PSAT1 PDLIM7 CCDC80 CCN4 SLIT1 UGDH C7	9.59e-07	200	168	8	94e77a1082ade6fad93a37168e037af8aefe7ff4
ToppCell	droplet-Liver-HEPATOCYTES-1m-Epithelial-Hepatocyte_(Pericentral)\|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	GPD1 PSAT1 AOX1 POR BDH1 EHHADH UGDH	2.58e-06	160	168	7	c42bcc6c7d113f0db43febb088b75ca4ac7cb7a3
ToppCell	15-Distal-Epithelial-Multiciliated_cell\|Distal / Age, Tissue, Lineage and Cell class	DNAH10 DNAH2 CFAP43 AK7 C6orf118 C6 DNAH9	3.70e-06	169	168	7	425d89ab69e9f9eb3df84056676423e390cc6ab1
ToppCell	3'-Broncho-tracheal-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.0.2\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	DNAH10 ANKUB1 DNAH2 CFAP43 C6orf118 SLIT1 DNAH9	3.70e-06	169	168	7	14aadc2d1bf66eb47dac33b4d61ddb3c942caa4f
ToppCell	TCGA-Liver-Primary_Tumor-Hepatocellular_Carcinoma-Hepatocellular_Carcinoma-8\|TCGA-Liver / Sample_Type by Project: Shred V9	GPD1 SUCLG2 F9 BDH1 C6 C7 UPP2	4.00e-06	171	168	7	c4a919fe3d56ae6df2fcab6686abacc10befc053
ToppCell	facs-GAT-Fat-18m-Lymphocytic-T_cell\|GAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation	SCN11A TDRD9 SEPTIN6 GIMAP8 UHRF2 RAB37 FAM83A	4.16e-06	172	168	7	17a486c5d0430abb133eab9f087e2ef8b60f7d25
ToppCell	Ciliated_cells-A-IPF_01\|World / lung cells shred on cell class, cell subclass, sample id	DNAH10 ANKUB1 DNAH2 CFAP43 C6orf118 C6 DNAH9	5.21e-06	178	168	7	255473ee6df8a13079fb3bb61038162a40cb4c2c
ToppCell	Mid-temporal_gyrus_(MTG)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_VIP_1-Inh_L1_SST_CXCL14\|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	RELN AVPR1A CARMIL3 P4HA3 NCKAP5 EGFR SCN5A	5.61e-06	180	168	7	b6efdb4d319ef6f87f559acd974e5a71b06a2322
ToppCell	Control-Epithelial_cells-Airway_ciliated\|Control / group, cell type (main and fine annotations)	DNAH10 DNAH2 CFAP43 AK7 C6orf118 C6 DNAH9	6.03e-06	182	168	7	fb725d10d9ed25dfc6d5bb69cfef78513f7d3e8f
ToppCell	Fetal_29-31_weeks-Endothelial-endothelial_cell_of_lymph_vessel-D088\|Fetal_29-31_weeks / Lineage, Cell type, age group and donor	RELN STAB2 ABCA4 PKHD1L1 CLIC2 SV2B UHRF2	6.25e-06	183	168	7	bc98df870de65aff6dab295c24cbc199c7f2aa15
ToppCell	droplet-Lung-nan-21m-Endothelial-endothelial_cell_of_lymphatic_vessel\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	RELN STAB2 DAPK2 GRIA2 PKHD1L1 NAV3 WDR73	6.71e-06	185	168	7	3a4ae836e882e8d29eb0a2dfab5677f10f2d365f
ToppCell	droplet-Lung-nan-21m-Endothelial-Lymphatic_endothelial_cell\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	RELN STAB2 DAPK2 GRIA2 PKHD1L1 NAV3 WDR73	6.71e-06	185	168	7	224f0b022c21dd40bf1f7503f00b3107ef958975
ToppCell	NS-moderate-d_16-33-Epithelial-Ciliated\|d_16-33 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined)	DNAH10 ANKUB1 DNAH2 CFAP43 AK7 C6orf118 DNAH9	6.71e-06	185	168	7	5e689c2fb36ce3ac2adc8d15f67107f21cf68868
ToppCell	15-Airway-Epithelial-Multiciliated_cell\|Airway / Age, Tissue, Lineage and Cell class	DNAH10 DNAH2 CFAP43 AK7 C6orf118 C6 DNAH9	6.71e-06	185	168	7	0998b6bf44287eebbf39249fff23fc3689e44c4e
ToppCell	Adult-Epithelial-ciliated_cell-D175\|Adult / Lineage, Cell type, age group and donor	DNAH10 DNAH2 CFAP43 AK7 C6orf118 C6 DNAH9	6.71e-06	185	168	7	30f4980dee6cd5959655f8d74049f3bfb5312611
ToppCell	NS-moderate-d_07-13-Epithelial-Ciliated\|d_07-13 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined)	DNAH10 ANKUB1 DNAH2 CFAP43 AK7 C6orf118 DNAH9	6.95e-06	186	168	7	85787ff207f109ec7e3c0f729ba9bda739c2fdc9
ToppCell	Ciliated_cells-B-IPF_01\|World / lung cells shred on cell class, cell subclass, sample id	DNAH10 ANKUB1 DNAH2 CFAP43 C6orf118 C6 DNAH9	6.95e-06	186	168	7	f72267d533fd0c5280d9741ceee3dd116300a7e4
ToppCell	Ciliated_cells-B-HP_01\|World / lung cells shred on cell class, cell subclass, sample id	DNAH10 ANKUB1 DNAH2 CFAP43 C6orf118 C6 DNAH9	7.20e-06	187	168	7	bc1f33f332ac939c2425f510173430ca2ba0c3ee
ToppCell	Ciliated_cells-B-Donor_07\|World / lung cells shred on cell class, cell subclass, sample id	DNAH10 ANKUB1 DNAH2 CFAP43 C6orf118 C6 DNAH9	7.45e-06	188	168	7	606907c865bd2f11bb6474932716550f7723d858
ToppCell	facs-Trachea-24m-Mesenchymal-myofibroblast-tracheobronchial_smooth_muscle_cell-smooth_muscle_cell_of_trachea_l32-30\|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	ERBB2 RELN TXNRD2 MORC4 FREM1 EHHADH NAV3	7.45e-06	188	168	7	c2febf9fd4632af1f922067c3a30e5c50f75f480
ToppCell	PBMC-Mild-cDC_12\|Mild / Compartment, Disease Groups and Clusters	PSAT1 WEE1 DTL OAS3 WDR76 UTP20 PRKDC	7.71e-06	189	168	7	946c95d2ecc36b241f58e8c4ad6455fe47c762fa
ToppCell	cellseq2-Epithelial-Epithelial_Airway-Ciliated/Deuterosomal\|cellseq2 / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2	DNAH10 ANKUB1 DNAH2 CFAP43 AK7 C6orf118 DNAH9	7.71e-06	189	168	7	a3cd4c2da4feb9bdcd8957f3e344d095da1367b8
ToppCell	COVID-19-lung-Ciliated\|lung / Disease (COVID-19 only), tissue and cell type	DNAH10 DNAH2 CFAP43 AK7 C6orf118 C6 DNAH9	7.71e-06	189	168	7	27329c4661aebabd19fac7fe5dca263fe99d76f3
ToppCell	Ciliated\|World / shred by cell class for parenchyma	DNAH10 ANKUB1 DNAH2 CFAP43 C6orf118 C6 DNAH9	7.71e-06	189	168	7	711181ca3b9102fb155168b646b0a9b09ff215b2
ToppCell	Adult-Epithelial-ciliated_cell\|Adult / Lineage, Cell type, age group and donor	DNAH10 DNAH2 CFAP43 AK7 C6orf118 C6 DNAH9	7.71e-06	189	168	7	b679920f0993e917dd86da082113bfbd85ea1ca5
ToppCell	COPD-Epithelial-Ciliated\|Epithelial / Disease state, Lineage and Cell class	DNAH10 DNAH2 CFAP43 AK7 C6orf118 C6 DNAH9	7.71e-06	189	168	7	3e77883db34722b9ce0a03ea74caefc92dc7feff
ToppCell	cellseq2-Epithelial-Epithelial_Airway-Ciliated/Deuterosomal-Ciliated\|cellseq2 / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2	DNAH10 ANKUB1 DNAH2 CFAP43 AK7 C6orf118 DNAH9	7.71e-06	189	168	7	93b1026bb1ba759e5704561c9a5de14a30c08894
ToppCell	343B-Epithelial_cells-Epithelial-F_(Ciliated)\|343B / Donor, Lineage, Cell class and subclass (all cells)	DNAH10 ANKUB1 DNAH2 CFAP43 C6orf118 C6 DNAH9	7.98e-06	190	168	7	169e600e95878000acf5d11f813f9028c7249646
ToppCell	cellseq2-Epithelial-Epithelial_Airway\|cellseq2 / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2	DNAH10 ANKUB1 DNAH2 CFAP43 AK7 C6orf118 DNAH9	7.98e-06	190	168	7	17829f4de31b3d9e4d71ba4817d18842aa699773
ToppCell	Control-Fibroblasts\|Control / group, cell type (main and fine annotations)	AOX1 CCDC80 SVEP1 FREM1 GALNT17 NAV3 C7	7.98e-06	190	168	7	3a42a9b98d954685d38a741f44545898d0e3e9ce
ToppCell	343B-Epithelial_cells-Epithelial-F_(Ciliated)-\|343B / Donor, Lineage, Cell class and subclass (all cells)	DNAH10 ANKUB1 DNAH2 CFAP43 C6orf118 C6 DNAH9	7.98e-06	190	168	7	0cc36117c793d83cf4a1f66f47758a07d6712bd3
ToppCell	Ciliated_cells-B\|World / lung cells shred on cell class, cell subclass, sample id	DNAH10 ANKUB1 DNAH2 CFAP43 C6orf118 C6 DNAH9	7.98e-06	190	168	7	7031fbedc13be1a00f6333ad6d51849c3739c2e6
ToppCell	Epithelial_cells-Ciliated_cells-B\|Epithelial_cells / lung cells shred on cell class, cell subclass, sample id	DNAH10 ANKUB1 DNAH2 CFAP43 C6orf118 C6 DNAH9	7.98e-06	190	168	7	426a4806f6e39d4d57c6746609d30bb3ca62df7d
ToppCell	BAL-Control-Epithelial-Epithelial-Ciliated\|Control / Location, Disease Group, Cell group, Cell class (2021.03.09)	DNAH10 ANKUB1 DNAH2 CFAP43 AK7 C6orf118 DNAH9	8.26e-06	191	168	7	7b5da29109aa28768c67653a1bc0f385c2d2269b
ToppCell	BAL-Mild-Epithelial-Epithelial-Ciliated-\|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	DNAH10 ANKUB1 DNAH2 CFAP43 AK7 C6orf118 DNAH9	8.26e-06	191	168	7	46c9d4d10c66c0fae1fa351924091b69ea2f38d4
ToppCell	BAL-Control-Epithelial\|Control / Location, Disease Group, Cell group, Cell class (2021.03.09)	DNAH10 ANKUB1 DNAH2 CFAP43 AK7 C6orf118 DNAH9	8.26e-06	191	168	7	9f19098f260d5542aa8ba7eb6f91b44d0db6e0a4
ToppCell	BAL-Control-Epithelial-Epithelial-Ciliated-\|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	DNAH10 ANKUB1 DNAH2 CFAP43 AK7 C6orf118 DNAH9	8.26e-06	191	168	7	fa9f8b50bfc7911c858bc2f9dcd204873d97ac61
ToppCell	facs-Lung-nan-3m-Endothelial-Lymphatic_endothelial_cell\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	RELN STAB2 DAPK2 GRIA2 PKHD1L1 SCN5A NAV3	8.26e-06	191	168	7	48823a97c38263f2c6e58348214f5b62773a6368
ToppCell	BAL-Control-Epithelial-Epithelial-Ciliated\|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	DNAH10 ANKUB1 DNAH2 CFAP43 AK7 C6orf118 DNAH9	8.26e-06	191	168	7	c4b223b33c020a064f576711a3d700eb60a2d737
ToppCell	Mild_COVID-19-Epithelial-Ciliated\|Mild_COVID-19 / Disease group,lineage and cell class （2021.01.30）	DNAH10 ANKUB1 DNAH2 CFAP43 AK7 C6orf118 DNAH9	8.26e-06	191	168	7	995e76bbf07674d95b8ef09e078cf6410af27a09
ToppCell	BAL-Control-Epithelial\|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	DNAH10 ANKUB1 DNAH2 CFAP43 AK7 C6orf118 DNAH9	8.26e-06	191	168	7	5129f778a9283bfac4ff322c21c5ca71da4b7174
ToppCell	BAL-Mild-Epithelial-Epithelial-Ciliated\|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	DNAH10 ANKUB1 DNAH2 CFAP43 AK7 C6orf118 DNAH9	8.26e-06	191	168	7	a37f20172b85566b9039254a89680e37fd503fd5
ToppCell	BAL-Control-Epithelial-Epithelial\|Control / Location, Disease Group, Cell group, Cell class (2021.03.09)	DNAH10 ANKUB1 DNAH2 CFAP43 AK7 C6orf118 DNAH9	8.26e-06	191	168	7	df8a1a6e78aa0cb941b94cb676bd6891d79f3687
ToppCell	Healthy_Control-Epithelial\|Healthy_Control / Condition, Lineage, Cell class and cell subclass	DNAH10 ANKUB1 DNAH2 CFAP43 AK7 C6orf118 DNAH9	8.26e-06	191	168	7	fdcdadbfc9ccae175abe4de8c7428ac4f6a67fde
ToppCell	Control-Epithelial-Ciliated\|Control / Disease group,lineage and cell class （2021.01.30）	DNAH10 ANKUB1 DNAH2 CFAP43 AK7 C6orf118 DNAH9	8.26e-06	191	168	7	cdc08e95a0c8f5c7a8d01b6bbaafdb54ef2f0d12
ToppCell	facs-Lung-nan-3m-Endothelial-endothelial_cell_of_lymphatic_vessel\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	RELN STAB2 DAPK2 GRIA2 PKHD1L1 SCN5A NAV3	8.26e-06	191	168	7	0eedc66e967b1837ce2c14f8c14b3c1eba868c76
ToppCell	nucseq-Epithelial-Epithelial_Airway\|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2	DNAH10 DNAH2 CFAP43 AK7 C6orf118 C6 DNAH9	8.26e-06	191	168	7	1c528f72c9ef3ef3a850b05e4a9715190832270c
ToppCell	BAL-Mild-Epithelial-Epithelial-Ciliated-\|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09)	DNAH10 ANKUB1 DNAH2 CFAP43 AK7 C6orf118 DNAH9	8.26e-06	191	168	7	2a8e6d560907e71e9f6e190ca0667da804e25641
ToppCell	Healthy_Control-Epithelial-Epithelial-\|Healthy_Control / Condition, Lineage, Cell class and cell subclass	DNAH10 ANKUB1 DNAH2 CFAP43 AK7 C6orf118 DNAH9	8.26e-06	191	168	7	28caedb2e448e0c7f494100d714fa7cdcf150691
ToppCell	BAL-Control-Epithelial-Epithelial-Ciliated-\|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09)	DNAH10 ANKUB1 DNAH2 CFAP43 AK7 C6orf118 DNAH9	8.26e-06	191	168	7	b4e335e798c9617356b8e24412f9270c42dce656
ToppCell	BAL-Mild-Epithelial-Epithelial-Ciliated\|Mild / Location, Disease Group, Cell group, Cell class (2021.03.09)	DNAH10 ANKUB1 DNAH2 CFAP43 AK7 C6orf118 DNAH9	8.26e-06	191	168	7	2d36e08c5629cf73b6dd02cd173cafb52e8a3a7d
ToppCell	Healthy_Control-Epithelial-Epithelial\|Healthy_Control / Condition, Lineage, Cell class and cell subclass	DNAH10 ANKUB1 DNAH2 CFAP43 AK7 C6orf118 DNAH9	8.26e-06	191	168	7	15b9386b26caaa7d15f704c4a18881e1ce918a21
ToppCell	nucseq-Epithelial-Epithelial_Airway-Ciliated/Deuterosomal-Ciliated\|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2	DNAH10 DNAH2 CFAP43 AK7 C6orf118 C6 DNAH9	8.26e-06	191	168	7	e417bf491f8b8d7838a61f7f4f6b1740ba97aa3f
ToppCell	Control-Epithelial\|Control / Disease group,lineage and cell class （2021.01.30）	DNAH10 ANKUB1 DNAH2 CFAP43 AK7 C6orf118 DNAH9	8.26e-06	191	168	7	b78547dae8328244a47c83346447bdd787efbcae
ToppCell	nucseq-Epithelial-Epithelial_Airway-Ciliated/Deuterosomal\|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2	DNAH10 DNAH2 CFAP43 AK7 C6orf118 C6 DNAH9	8.26e-06	191	168	7	9d31c8424d35bdc0c27188b68bfd0f731af3600b
ToppCell	BAL-Control-Epithelial-Epithelial\|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	DNAH10 ANKUB1 DNAH2 CFAP43 AK7 C6orf118 DNAH9	8.26e-06	191	168	7	c50d6a1a6209ed4157f7c00fc24d4ecb43790f44
ToppCell	Mesenchymal_cells-Ng2+_MSCs\|World / Lineage and Cell class	DAPK2 MPZL1 NCAM1 CCDC80 CCN4 WIF1 NAV3	8.55e-06	192	168	7	0703b8ec6960ff975ee5a2737054db67cab016b5
ToppCell	IPF-Epithelial-Ciliated\|IPF / Disease state, Lineage and Cell class	DNAH10 DNAH2 CFAP43 AK7 C6orf118 C6 DNAH9	8.55e-06	192	168	7	354adc1354bf596fbc60dd45c0169688e6f45165
ToppCell	NS-moderate-d_0-4\|moderate / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined)	DNAH10 ANKUB1 DNAH2 CFAP43 C6orf118 EGFR DNAH9	8.84e-06	193	168	7	ea345d34440b25f65358a53dc72831998d1c3620
ToppCell	Parenchymal-NucSeq-Stromal-Fibroblastic-Fibro_perichondrial\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	CPA4 PRSS3 AVPR1A CSMD2 FREM1 NAV3 C6	8.84e-06	193	168	7	e5016959f24370579a8770787e96869f264cf7b3
ToppCell	NS-critical-d_07-13-Epithelial-Ciliated\|d_07-13 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined)	DNAH10 ANKUB1 DNAH2 CFAP43 AK7 C6orf118 DNAH9	9.14e-06	194	168	7	1ae8a10e508e672e6677f0e3c986ac30d05adeb3
ToppCell	wk_20-22-Epithelial-Proximal_epithelial-MUC16+_ciliated\|wk_20-22 / Celltypes from embryonic and fetal-stage human lung	DNAH10 ANKUB1 DNAH2 CFAP43 AK7 C6orf118 DNAH9	9.14e-06	194	168	7	756082a0f5953b52229bb60d40b84701cb6cb23d
ToppCell	Control-Fibroblasts-Intermediate_pathological_FB\|Control / group, cell type (main and fine annotations)	PDLIM7 CCDC80 CSMD2 SVEP1 CCN4 NAV3 C7	9.14e-06	194	168	7	03a269f75a481ea54aea8e6444605db8d6df493d
ToppCell	wk_15-18-Epithelial-Proximal_epithelial\|wk_15-18 / Celltypes from embryonic and fetal-stage human lung	DNAH10 DNAH2 CFAP43 AK7 C6orf118 C6 DNAH9	9.14e-06	194	168	7	b0477583301dc6d9767b667bd2f8f94fbfaa6f81
ToppCell	COVID-19-Epithelial-Ciliated_cells\|COVID-19 / Condition, Lineage and Cell class	DNAH10 ANKUB1 DNAH2 CFAP43 AK7 C6orf118 DNAH9	9.14e-06	194	168	7	43be5fbd51dd58839cb03ca3ddd05a458e1ddb74
ToppCell	PBMC-Control\|PBMC / Compartment, Disease Groups and Clusters	ROGDI ESD NCKAP5 GZMA ARPIN ECI2 MAP2K2	9.46e-06	195	168	7	3cc4afa5f68f28336310d5f80a082cb8d98a5679
ToppCell	IPF-Stromal-Fibroblast\|World / Disease state, Lineage and Cell class	AOX1 CCDC80 SVEP1 EGFR UGDH NAV3 C7	9.46e-06	195	168	7	9c32756edb54f0c211185d9a98073fe01fd1526a
ToppCell	wk_15-18-Epithelial-Proximal_epithelial-Ciliated\|wk_15-18 / Celltypes from embryonic and fetal-stage human lung	DNAH10 DNAH2 CFAP43 AK7 C6orf118 C6 DNAH9	9.46e-06	195	168	7	cfcf554b436083179dea1d6fd6e3a800ea2430fe
ToppCell	NS-critical-LOC-Epithelial-Ciliated\|LOC / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined)	DNAH10 ANKUB1 CCDC80 CFAP43 AK7 C6orf118 DNAH9	9.46e-06	195	168	7	34e37cff4849696ca4ba5dd8fd2cf98fed8bc912
Disease	Adenocarcinoma of large intestine	ERBB2 RIPK1 PAK5 DAPK3 EGFR PRKDC	1.65e-05	96	164	6	C1319315
Disease	Head and Neck Carcinoma	ERBB2 EGFR PIK3CB	1.97e-05	10	164	3	C3887461
Disease	Adenocarcinoma of lung (disorder)	ERBB2 PSAT1 EML4 PAK5 IRAK1 SUCLG2 EGFR PRKDC	2.12e-05	206	164	8	C0152013
Disease	gliosarcoma	POR EGFR SEPTIN14	8.95e-05	16	164	3	C0206726
Disease	irritable bowel syndrome, anorexia nervosa	NCAM1 FAM120A	9.18e-05	3	164	2	EFO_0000555, MONDO_0005351
Disease	Degenerative polyarthritis	ACO1 ESD CLIC4 TXNRD1 SDHA	1.75e-04	93	164	5	C0029408
Disease	Osteoarthrosis Deformans	ACO1 ESD CLIC4 TXNRD1 SDHA	1.75e-04	93	164	5	C0086743
Disease	Non-Small Cell Lung Carcinoma	ERBB2 PSAT1 EML4 DAPK1 EGFR MAP2K2	2.46e-04	156	164	6	C0007131
Disease	Cetuximab response	ERBB2 EGFR	3.04e-04	5	164	2	cv:CN077967
Disease	porphyria (implicated_via_orthology)	ACO1 IREB2	3.04e-04	5	164	2	DOID:13268 (implicated_via_orthology)
Disease	Panitumumab response	ERBB2 EGFR	3.04e-04	5	164	2	cv:CN077999
Disease	CD97 antigen measurement	C6 C7	4.54e-04	6	164	2	EFO_0020250
Disease	carbonic anhydrase 4 measurement	C6 C7	4.54e-04	6	164	2	EFO_0020230
Disease	calcineurin subunit B type 1 measurement	C6 C7	6.33e-04	7	164	2	EFO_0020215
Disease	cardiomyopathy (implicated_via_orthology)	ERBB2 PDLIM7 EGFR SDHA	6.69e-04	71	164	4	DOID:0050700 (implicated_via_orthology)
Disease	Prostatic Neoplasms	ERBB2 STAB2 ADAM9 AOX1 CLIC4 TXNRD2 IVNS1ABP EGFR EHHADH PIK3CB PRKDC	6.95e-04	616	164	11	C0033578
Disease	Malignant neoplasm of prostate	ERBB2 STAB2 ADAM9 AOX1 CLIC4 TXNRD2 IVNS1ABP EGFR EHHADH PIK3CB PRKDC	6.95e-04	616	164	11	C0376358
Disease	Squamous cell carcinoma of lung	EGFR EPHA2 PRKDC	7.43e-04	32	164	3	C0149782
Disease	alcohol use disorder (implicated_via_orthology)	ERBB2 GRK7 CLIC4 EGFR CLIC2 PIK3CB	8.01e-04	195	164	6	DOID:1574 (implicated_via_orthology)
Disease	Head and Neck Neoplasms	ERBB2 EGFR PIK3CB	8.14e-04	33	164	3	C0018671
Disease	Brugada syndrome	GPD1L SCN5A	8.41e-04	8	164	2	cv:C1142166
Disease	Congenital adrenal hyperplasia	AVPR1A POR	1.08e-03	9	164	2	C0001627
Disease	apolipoprotein D measurement	C6 C7	1.08e-03	9	164	2	EFO_0020156
Disease	Cancer of Nasopharynx	EGFR WIF1	1.08e-03	9	164	2	C0238301
Disease	kallikrein-14 measurement	C6 C7	1.08e-03	9	164	2	EFO_0020513
Disease	Nasopharyngeal Neoplasms	EGFR WIF1	1.08e-03	9	164	2	C0027439
Disease	Malignant neoplasm of brain	EML4 DAPK1 EGFR	1.23e-03	38	164	3	C0153633
Disease	Autism Spectrum Disorders	RELN ROGDI AVPR1A UPP2	1.31e-03	85	164	4	C1510586
Disease	Brain Neoplasms	EML4 DAPK1 EGFR	1.33e-03	39	164	3	C0006118
Disease	generalized epilepsy with febrile seizures plus 2 (implicated_via_orthology)	SCN11A SCN5A	1.34e-03	10	164	2	DOID:0111294 (implicated_via_orthology)
Disease	tropomyosin beta chain measurement	C6 C7	1.34e-03	10	164	2	EFO_0020787
Disease	Dravet syndrome (implicated_via_orthology)	SCN11A SCN5A	1.34e-03	10	164	2	DOID:0080422 (implicated_via_orthology)
Disease	age at onset, multiple sclerosis	RELN NCKAP5	1.34e-03	10	164	2	EFO_0004847, MONDO_0005301
Disease	chronic fatigue syndrome (is_marker_for)	CD28 CCL24	1.34e-03	10	164	2	DOID:8544 (is_marker_for)
Disease	Neoplasm of uncertain or unknown behavior of breast	ERBB2 PIK3CB HERC2	1.54e-03	41	164	3	C0496956
Disease	Breast adenocarcinoma	ERBB2 PIK3CB HERC2	1.54e-03	41	164	3	C0858252
Disease	tumor necrosis factor receptor superfamily member 11B measurement	C6 C7	1.63e-03	11	164	2	EFO_0020801
Disease	Noonan Syndrome 1	EPHA2 MAP2K2	1.63e-03	11	164	2	C4551602
Disease	gallbladder neoplasm	ERBB2 EGFR	1.63e-03	11	164	2	C0016978
Disease	Turner Syndrome, Male	EPHA2 MAP2K2	1.63e-03	11	164	2	C0041409
Disease	Female Pseudo-Turner Syndrome	EPHA2 MAP2K2	1.63e-03	11	164	2	C1527404
Disease	Malignant neoplasm of gallbladder	ERBB2 EGFR	1.63e-03	11	164	2	C0153452
Disease	Malignant Head and Neck Neoplasm	ERBB2 EGFR PIK3CB	1.89e-03	44	164	3	C0278996
Disease	schizophrenia (is_marker_for)	RELN NCAM1 EGFR	1.89e-03	44	164	3	DOID:5419 (is_marker_for)
Disease	Familial dilated cardiomyopathy	TXNRD2 SCN5A SDHA	1.89e-03	44	164	3	C0340427
Disease	generalized epilepsy with febrile seizures plus (implicated_via_orthology)	SCN11A SCN5A	1.95e-03	12	164	2	DOID:0060170 (implicated_via_orthology)
Disease	complement component C7 measurement	C6 C7	1.95e-03	12	164	2	EFO_0008093
Disease	Papilloma	ERBB2 EGFR	1.95e-03	12	164	2	C0030354
Disease	Papillomatosis	ERBB2 EGFR	1.95e-03	12	164	2	C0205875
Disease	Papilloma, Squamous Cell	ERBB2 EGFR	1.95e-03	12	164	2	C0205874
Disease	tyrosine-protein kinase ZAP-70 measurement	C6 C7	1.95e-03	12	164	2	EFO_0020833
Disease	complement component C6 measurement	C6 C7	2.30e-03	13	164	2	EFO_0020281
Disease	Brugada Syndrome 1	GPD1L SCN5A	2.30e-03	13	164	2	C4551804
Disease	Disease Exacerbation	ERBB2 SUCLG1 ABCA7 EGFR EPHA2	2.34e-03	165	164	5	C0235874
Disease	Adenoid Cystic Carcinoma	DTL DAPK1 PRKDC MAP2K2	2.38e-03	100	164	4	C0010606
Disease	Cardiomyopathy, Dilated	EGFR SCN5A SDHA	2.43e-03	48	164	3	C0007193
Disease	Major Depressive Disorder	RELN GRIA2 NCAM1 CRHBP EGFR CCL24	2.45e-03	243	164	6	C1269683
Disease	retinal vasculature measurement	SEM1 ANKUB1 ABHD2 NCKAP5 TXNRD2 TXNRD1 NAV3 HERC2 DNAH9	2.51e-03	517	164	9	EFO_0010554
Disease	Neoplasm of lung	ERBB2 EGFR	2.67e-03	14	164	2	cv:C0024121
Disease	median neuropathy (biomarker_via_orthology)	ERBB2 EGFR	2.67e-03	14	164	2	DOID:571 (biomarker_via_orthology)
Disease	Lung cancer	ERBB2 EGFR	2.67e-03	14	164	2	cv:C0242379
Disease	LUNG CANCER	ERBB2 EGFR	2.67e-03	14	164	2	211980
Disease	Cardiomyopathy, Familial Idiopathic	PNPLA2 EGFR SDHA	2.73e-03	50	164	3	C1449563
Disease	facial width measurement	DAPK1 NCAM1 RAB37 FOXK1	2.84e-03	105	164	4	EFO_0007855
Disease	low density lipoprotein cholesterol measurement, response to selective serotonin reuptake inhibitor	NCAM1 CSMD2	3.07e-03	15	164	2	EFO_0004611, EFO_0005658
Disease	Unipolar Depression	RELN GRIA2 NCAM1 CRHBP EGFR CCL24	3.36e-03	259	164	6	C0041696
Disease	Metastatic melanoma	GRK7 PAK5 PRKDC	3.40e-03	54	164	3	C0278883
Disease	platelet component distribution width	VMP1 HBS1L SCN11A WEE1 MARK3 DAPK2 CLIC4 SVEP1 MPRIP EGFR TRDMT1	3.43e-03	755	164	11	EFO_0007984
Disease	Synostotic Posterior Plagiocephaly	FREM1 WDR35	3.50e-03	16	164	2	C1833340
Disease	infant expressive language ability	NCAM1 DAPK3	3.50e-03	16	164	2	EFO_0006316
Disease	Craniosynostosis, Type 1	FREM1 WDR35	3.50e-03	16	164	2	C4551902
Disease	Acrocephaly	FREM1 WDR35	3.50e-03	16	164	2	C0030044
Disease	Trigonocephaly	FREM1 WDR35	3.50e-03	16	164	2	C0265535
Disease	Scaphycephaly	FREM1 WDR35	3.50e-03	16	164	2	C0265534
Disease	Synostotic Anterior Plagiocephaly	FREM1 WDR35	3.50e-03	16	164	2	C2931150
Disease	Metopic synostosis	FREM1 WDR35	3.50e-03	16	164	2	C1860819
Disease	Brachycephaly	FREM1 WDR35	3.95e-03	17	164	2	C0221356
Disease	Phenyllactate (PLA) measurement	DAPK1 SLC38A7	4.93e-03	19	164	2	EFO_0021662
Disease	laryngeal squamous cell carcinoma (is_marker_for)	ERBB2 EGFR	4.93e-03	19	164	2	DOID:2876 (is_marker_for)
Disease	level of Sterol ester (27:1/20:3) in blood serum	USP24 NOMO1	4.93e-03	19	164	2	OBA_2045199
Disease	temporal lobe epilepsy (is_marker_for)	RELN ADK	5.46e-03	20	164	2	DOID:3328 (is_marker_for)
Disease	Craniosynostosis	FREM1 WDR35	5.46e-03	20	164	2	C0010278

Protein segments in the cluster

Peptide	Gene	Start	Entry
SCLGAKQGFKGFQVA	ACO1	391	P21399
ISSNKCFGGLQKVFE	ESD	6	P10768
IQEFAGCKKIFGSLA	ERBB2	361	P04626
GEELGSGQFAVVKKC	DAPK1	16	P53355
AGVIFTTKKGQQFCG	CCL24	61	O00175
CDGKFQAIDFITPGT	CFAP43	386	Q8NDM7
LFVKAGSDGESIGNC	CLIC4	21	Q9Y696
ATFFGCIGIDKFGEI	ADK	101	P55263
KGLQFGVGDTLTFSC	CSMD2	1051	Q7Z408
KTGFNCDGKLGNESV	CD28	81	P10747
ECFGLLGVNGAGKTT	ABCA4	1966	P78363
KAVLVTGCDSGFGFS	BDH1	56	Q02338
AVIFDNGSGFCKAGL	ACTRT2	11	Q8TDY3
KLDGCFDSVAILTGG	DUSP8	111	Q13202
LVVVGFSLGGNIVCK	ABHD2	201	P08910
VFRGVTSFGLENKCG	GZMA	221	P12544
VQKGECFGLLGFNGA	ABCA3	1406	Q99758
EAGTVTKCNFTGDGK	ARPIN	176	Q7Z6K5
KTIDVSFQCPDGLGF	CCN4	316	O95388
FEKAVFCTGGRDGNI	DTL	151	Q9NZJ0
ECFGLLGVNGAGKTS	ABCA7	1821	Q8IZY2
GFVQKCKASGVEGQV	CCDC80	276	Q76M96
VKAEFGGGTRGFSCE	ANO8	131	Q9HCE9
KGLGESGVFLGCSVF	AOX1	1266	Q06278
GEIKLCDFGVSGQLI	MAP2K2	206	P36507
GVSDICTKGGDINFV	NOMO3	111	P69849
GDTGVGKTCFLIQFK	RAB37	36	Q96AX2
GKTCFLIQFKDGAFL	RAB37	41	Q96AX2
LVTCGILSGNKNFEG	IREB2	601	P48200
FKDQGSGFCITGKIE	HBS1L	496	Q9Y450
SGFCITGKIEAGYIQ	HBS1L	501	Q9Y450
LFSLTGDDCFQVGKV	P4HA3	176	Q7Z4N8
CLTGGSGTNEFKFLK	PCDHB2	756	Q9Y5E7
CLTGGSGANEFKFLK	PCDHB18P	701	Q96TA0
KFFIGFGGKGANQCV	RBKS	46	Q9H477
NFIKIGEGSTGIVCI	PAK5	451	Q9P286
LVTGVCLGEAGAKFI	PNPLA2	56	Q96AD5
GICVKEQIPESAGFF	CRELD1	341	Q96HD1
ICKELIGSSLDFFGQ	KIF14	1241	Q15058
GVSDICTKGGDINFV	NOMO2	111	Q5JPE7
GNKAISRAGCGVQIF	OR2T12	86	Q8NG77
VVDGEGRTGQKFSLC	MPRIP	106	Q6WCQ1
VDLSGVKFAVFGLGN	POR	161	P16435
VLNGKLFVCGGFDGS	IVNS1ABP	556	Q9Y6Y0
LCGALKNIVAVGAGF	GPD1L	201	Q8N335
GLGVVKVECGSQFSV	HERC2	4196	O95714
FRVGKKIGCGNFGEL	CSNK1G2	46	P78368
GFTKDVGNIKFLVCA	RABIF	81	P47224
QKLAGVFGENGSCVL	CARMIL3	261	Q8ND23
KAIVICGAEGKFSAG	EHHADH	46	Q08426
DLLKIQFGGANVSGF	GRIA2	246	P42262
KSISFVGCGIQIGFF	OR2V1	91	Q8NHB1
KSISFVGCGIQIGLF	OR2V2	91	Q96R30
QGKAFVSGLLIGQCS	ODR4	21	Q5SWX8
KECGALGGLFQAIVN	MTSS2	6	Q765P7
TSDDFCLGFNIRGGK	PDZD7	216	Q9H5P4
VGSLSDIFNGFLNCK	NAV3	2131	Q8IVL0
QVVLNGKVDAFCGGS	F9	241	P00740
GKVDAFCGGSIVNEK	F9	246	P00740
GKGFLFTVADLQAGV	FREM1	466	Q5H8C1
GVSDICTKGGDINFV	NOMO1	111	Q15155
GEELGSGQFAIVRKC	DAPK3	16	O43293
VGKSDGFGDFSCLKI	NFX1	546	Q12986
SQVAFGGFILCKEGE	LILRB2	146	Q8N423
KVALLELGCGTGANF	METTL7B	71	Q6UX53
GVFVCVLLDQGGVKL	FAM83A	186	Q86UY5
IRDFNTNKCKGFGFV	ELAVL1	276	Q15717
LAKACFGGNIELFVF	FAM120A	81	Q9NZB2
SGFNGEILCQLKGNF	PCDHGB3	376	Q9Y5G1
NFSEELKIGEGGFGC	IRAK1	211	P51617
GTCIGATNKFGAEEK	MFSD11	261	O43934
IFVANGTQGKLTCKF	MPZL1	46	O95297
VVCFLGGSEKGLELF	C17orf75	151	Q9HAS0
FVCSQCGKVLEEGGF	PDLIM7	306	Q9NR12
KLSLLEVGCGTGANF	METTL7A	71	Q9H8H3
FGCGVLASGKALVFN	RELN	736	P78509
EVGQGKGFGVVCFSS	PABPC5	336	Q96DU9
VCLTGGSGTNEFKFL	PCDHB7	751	Q9Y5E2
VCNGIGIGEFKDSLS	EGFR	336	P00533
GEVLDNSFTGGICKT	C6	206	P13671
SIDCQGGDFLKVFDG	CRHBP	101	P24387
GEELGSGQFAIVKKC	DAPK2	26	Q9UIK4
SCVTRQKVIGAGEFG	EPHA2	611	P29317
FIGALIGSSICGQEK	CPA4	6	Q9UI42
IGSSICGQEKFFGDQ	CPA4	11	Q9UI42
GACKTAVQLLFGQAG	GARRE1	406	O15063
FGGQCRKVFSGDGKD	C7	161	P10643
CEKGDTFFVLVFQLG	GIMAP8	521	Q8ND71
GKVFEDICNSSLIFG	C6orf118	271	Q5T5N4
RCLGKNGVFVDGAFQ	FOXK1	161	P85037
IGCSFVVNRKFFGEI	GALNT17	326	Q6IS24
ECFGLLGVNGAGKTS	ABCA2	2081	Q9BZC7
IEVNSKGDRFGNCGF	ADAM9	541	Q13443
GALKNVVAVGAGFCD	GPD1	201	P21695
NEFTVGGKLDTFCGS	MARK3	201	P27448
KIEGDNISGVCFVGL	FZD3	351	Q9NPG1
EQKTGFAFVGILCIF	CTXN2	26	P0C2S0
TSINCFGDFIIFLGK	SLC44A3	526	Q8N4M1
IFGKKLTAGEACAQG	ECI2	301	O75521
PKFVQCLAFLGNGDV	EML4	456	Q9HC35
VKGGFCDIVEGLITS	DNAH9	941	Q9NYC9
TELNGGFFKGCIQDV	CRB1	841	P82279
VLGKGGFGEVCAVQV	GRK7	196	Q8WTQ7
GFGEVCAVQVKNTGK	GRK7	201	Q8WTQ7
GDYITGCKQAIGKFE	DNAH10	756	Q8IVF4
IAEIILFGEGFGNCK	DNAH2	1936	Q9P225
LFVKAGSDGESIGNC	CLIC2	16	O15247
QEEGQSKGFGLICFS	PABPC4L	326	P0CB38
GTALKGGCDSELVIF	OAS3	66	Q9Y6K5
GGFSGKCTVLIQVID	PCDHB8	326	Q9UN66
CTGFIFQKVGKLAAT	FUNDC2	96	Q9BWH2
AIDFSFCLKGEGLDG	RUNDC3B	196	Q96NL0
GKGVACITLAFVDEG	SZT2	2291	Q5T011
FGDVKFVCVGGSPNR	UPP2	56	O95045
VDKGSFGKGNLFVLC	UTP20	551	O75691
FILGSCGTDQVKGVL	ROGDI	61	Q9GZN7
FDGSIQCSGKDAILF	TRDMT1	216	O14717
CGVSTANGKGVKIEF	RNF19B	446	Q6ZMZ0
FTFNILCVGETGIGK	SEPTIN14	51	Q6ZU15
GESISCFQVGGEKRL	SKIL	151	P12757
NGLCKFGAILGNTIF	SV2B	631	Q7L1I2
FRVGSVLQEGCGKIS	SDHA	526	P31040
FRQCGQVKSIVFDGA	TDRD9	796	Q8NDG6
VSQVAFGSFILCKEG	LILRA1	146	O75019
NLDVLVGFGKSLCGS	NCKAP5	616	O14513
GFCRGFQGQLKDVQV	OPLAH	251	O14841
QEGAVFLSFKLVQGG	OPLAH	876	O14841
GFDLGCLQLTNEKVG	NBEAL2	2231	Q6ZNJ1
ILVFLCFGVTQAKDG	PTDSS2	101	Q9BVG9
KVIFLQGGGCGQFSA	PSAT1	71	Q9Y617
IKKSQCPIGVFGNGF	MORC4	111	Q8TE76
FAGKFGRCINQTEGD	SCN5A	1356	Q14524
IGKVISVIGGLAACF	SLC38A7	391	Q9NVC3
KKILSLCNTFGGGVF	SLC39A3	41	Q9BRY0
SNICAVFAVQGGKVG	SEM1	6	Q6ZVN7
QVKLTNSEGKDFCGG	PROZ	191	P22891
GKTGNTEKFGRFRQC	PIK3CB	971	P42338
AELDSGGFGKVSLCF	RIPK1	21	Q13546
GSKVNLFCDPGFQLV	SVEP1	1651	Q4LDE5
FCFNILCVGETGLGK	SEPTIN6	41	Q14141
TKIICQGFTGKQGTF	SUCLG1	56	P53597
VNGTACGEIKITDFG	TLK2	601	Q86UE8
AGEVVKTAGGVCKFS	ADGRD2	46	Q7Z7M1
SQFCGARVFGAKVGD	ANKUB1	331	A6NFN9
ISVGESKFFLCQVAG	NCAM1	31	P13591
VGATSFGIGCAEVNK	TMPRSS3	416	P57727
GEVTQGFAAALKCGL	TXNRD1	596	Q16881
FLGGSEGTLNDCKII	UHRF2	286	Q96PU4
LKASVGFGGSCFQKD	UGDH	266	O60701
GFGGSCFQKDVLNLV	UGDH	271	O60701
TCDIIFLNGGKPANF	SUCLG2	316	Q96I99
GSGEFGSVFKCVKRL	WEE1	306	P30291
GEQFSVLGQCGKAFS	ZNF778	166	Q96MU6
IQIELTKAAFGCFGN	WDR75	386	Q8IWA0
ATCGKGFGQRSDLVV	ZNF672	286	Q499Z4
CREYGKSFGQKGNLI	ZNF417	326	Q8TAU3
VFQILDGNTKCFISG	TMPRSS12	196	Q86WS5
KAGYTGDGIVCLEIN	STAB2	1501	Q8WWQ8
VGFPCLGKQDGVAAF	WIF1	136	Q9Y5W5
GEFATQTCLQGKFGE	PKHD1L1	2416	Q86WI1
FGGQTALNCGVELTK	CAD	476	P27708
QAGVAFQKGFLLAPC	AVPR1A	261	P37288
IIAAEKCFGTGAAGN	PRKDC	1306	P78527
FCVGFLEGGKDSCQR	PRSS3	241	P35030
GGGKTFDFKECGQVL	ZNF180	296	Q9UJW8
AVGAKFGQVGLCDLT	WDR76	331	Q9H967
GEVTQGFALGIKCGA	TXNRD2	471	Q9NNW7
FCENFLKAGGLSLVV	USP24	1201	Q9UPU5
GKDFVATAGFLQCEV	ZNF792	216	Q3KQV3
SGKFGKCINGTDSVI	SCN11A	1201	Q9UI33
IVCFAQGGGKETLKA	TRPM8	301	Q7Z2W7
VKFGDSKVIGQFECV	WDCP	46	Q9H6R7
QGFIACGGEDGLLKV	WDR35	26	Q9P2L0
GFGGPECEKLLSVNF	SLIT1	1156	O75093
GLKNCLAISGFDGTV	WDR73	286	Q6P4I2
LVQKVGFFGILACAS	VMP1	251	Q96GC9
GNIGKFLSNCVVGAS	AK7	31	Q96M32